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                             Introduction  
1. Introduction 
1.1 Pathogens and immunity 
Our earth is now 4.6 billion years’ old and the earliest life on our planet appeared 
approximately 4 billions years ago. Under the pressure of natural selection, life on earth 
evolved from single cell organisms (prokaryotes) to multicellular organisms (eukaryotes), as 
complicated as ourselves. During the evolution of life, some different organisms tend to live 
together to benefit each other (synbiosis). They either live in proximity or one lives inside of 
the other. One famous example is the adoption of cyanobacteria and proteobacteria by host 
cells which gave rise to chloroplasts and mitochondria, respectively (Margulis 1975; Sagan 
1993). This co-adaptation can also been seen in our human beings that the beneficial bacteria 
flourish in the gastrointestinal tracts.  
However, this is not always the case. Some microorganisms have evolved special mechanisms 
to invade, colonize and multiply in the host body at the expense of disturbing the normal 
physiology of the hosts. The disease-causing microorganisms are termed pathogens (from 
Greek pathos (suffering/emotion) and gene (to give birth to)). Traditionally, pathogens are 
divided into five main groups: viruses (including bacteriophages), bacteria, fungi, protozoa 
and worms. On the other hand, under the pressure of invading pathogens, the host organisms, 
especially the multicellular organisms such as vertebrates and plants, evolved sophisticated 
defense systems to resist the infection of pathogens. This defense mechanism in host 
organisms is therefore termed immunity (derived from Latin immunis, meaning exemption 
from public services).  
The immune system protects the host organisms from being overrun by the invading 
pathogens with multiple layered defense mechanisms. Most simply, the physical barriers 
prevent the pathogens from entering the body. If a pathogen breaches these barriers, the innate 
immune system provides an immediate, but non-specific response. The innate system is 
thought to constitute an evolutionarily older defense strategy, and is the dominant immune 
system found in plants, fungi, insects, and primitive multicellular organisms (Janeway 2001). 
Even simple unicellular organisms such as bacteria possess enzyme systems to protect against 
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the viral infections. Other innate immune mechanisms include antimicrobial peptides called 
defensins, phagocytosis, and the complement system. However, if the pathogens successfully 
evade the innate immune responses, the vertebrates possess a third layer of protection, the 
adaptive immune system, which is activated by the innate immune responses. This improved 
response is then retained after the pathogens have been eliminated, in the form of an 
immunological memory, and allows the adaptive immune system to mount faster and stronger 
attacks each time this specific pathogen is encountered again (Janeway 2001). 
Recognition of the infectious microorganism is the first and crucial step in immunity. Both 
innate and adaptive immunity depend on the ability of the immune system to distinguish 
between self and non-self molecules. When the pathogens invade the host, they are first 
recognized by the host innate immune system. In the innate immune system, the immune 
response is initiated by cells and molecules recognizing conserved features of microorganisms 
and activated immediately on encounter with them. These conserved features of pathogens are 
referred to as pathogen-associated molecular patterns (PAMPs), which include cell wall 
components (lipopolysaccharide, lipoprotein, peptidoglycan, flagellin, etc.), double-stranded 
RNA from viruses, or CpG-containing DNA. The recognition of PAMPs is accomplished by 
innate immune receptors termed pattern recognition receptors (PRRs). The list of PRRs is 
constantly expanding. Perhaps the most prominent PRRs include Toll-like receptors, the 
mannose receptor, Nod like receptors, and Plant R Proteins (Janeway 2002). For many host 
organisms, the innate immune system is enough to effectively eliminate most of the pathogens. 
For vertebrates, the innate immune system not only could directly eliminate the pathogens, 
but also could provide signals to further activate the adaptive immune system. The adaptive 
immune system, compared to innate immune system, is composed of highly specialized cells 
and molecules, which can recognize essentially unlimited numbers of different targets. This 
system is adaptive because it prepares itself for future challenges and it is highly adaptable 
because of irreversible genetic recombination and somatic hypermutation in the antigen 
receptor (TCRs and BCRs) gene segments (Janeway 2001).   
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1.2 Cytokines and interferons 
Cytokines are a group of intercellular regulatory proteins and peptides with a mass of between 
8 and 30 kDa, which are produced by a wide variety of cell types (both haemopoietic and 
non-haemopoietic) (DeFranco 2007). They play important roles in both innate and adaptive 
immunity, and some of them serve as bridges to transduce signals from innate immune system 
to activate the adaptive immune system. According to the structures, cytokines can be 
grouped into four families: the chemokines, the hematopoietins, the interferons (IFNs), and 
the tumor necrosis factor (TNF) family (Janeway 2001). The cytokines function in every 
aspects of immune response, including facilitating inflammation, activation of macrophages, 
T and B lymphocytes, chemotaxis, and also negative regulation of immune response 
(DeFranco 2007). Generally, cytokines are pleiotropic, multifunctional and sometimes 
redundant.  
The interferons were originally discovered by their ability to induce resistance to viral 
infection in cells (Isaacs 1957). It was later appreciated that, in addition to regulating 
resistance to viral infection, interferons are widely functional in innate and adaptive immunity, 
including activation of macrophages and NK cells, enhancement of antigen presentation by 
induction of major histocompatibility complex (MHC) class I and II molecules, as well as 
modulation of normal and tumour cell survival and death (Boehm 1997; Schroder 2004; 
Borden 2007). They are nowadays extensively used in clinical practice for treatment of viral 
diseases, cancer, as well as autoimmune disease multiple sclerosis (MS) (Borden 2007).  
According to sequence homology and molecular structures, as well as their receptor 
specificity, interferons are classified into three groups: Type I interferons, including IFN-α 
(14-20 members, depending on species) (van Pesch 2004), IFN-β (Mogensen 1999), IFN-ω 
(Hauptmann 1985), IFN-κ (LaFleur 2001), IFN-ε (Pestka 2004), IFN-δ (pigs) (Lefevre 1998) 
and IFN-τ (ruminants) (Bazer 1997); Type II interferon (IFN-γ as sole member) (Bancroft 
1993); Type III interferons, IFN-λs (3 members) (Kotenko 2003; Lasfar 2006). The type I 
interferons are synthesized and secreted by almost all nucleated cells when confronted with 
viral infection, while type II interferon (IFN-γ) is mainly secreted by activated T cells, NK 
cells and macrophages (Schroder 2004; Borden 2007). Each type of interferons is recognized 
by corresponding heterodimeric receptors, which signals mainly through JAK/STAT (Janus 
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kinase/Signal Transducers and Activators of Transcription) pathways (Figure 1.1). The 
activated STATs and other transcription factors (IRFs, interferon regulatory factors) are then 
translocated into the nucleus and drive the transcription and expression of interferon-
stimulated genes (ISGs) promoted by IFN-γ-activated site (GAS) elements and IFN-
stimulated response elements (ISREs) (Schroder 2004; Borden 2007). 
 
Figure 1.1 Simplified scheme of interferon receptors and signaling pathways (from Borden 2007). 
Type I interferons (IFNs) (α, β ω, κ, ε, δ (pigs), τ (ruminants)) interact with IFN (α, β and ω) receptor 1 (IFNAR1) and 
IFNAR2; type II IFN-γ with IFN-γ receptor 1 (IFNGR1) and IFNGR2; and type III IFN-λs with IFN-λ receptor 1 (IFNLR1; 
also known as IL28RA) and interleukin 10 receptor 2 (IL10R2; also known as IL10RB). Type II IFN-γ is an antiparallel 
homodimer exhibiting a two-fold axis of symmetry. It binds two IFNGR1 receptor chains, assembling a complex that is 
stabilized by two IFNGR2 chains. These receptors are associated with two kinases from the JAK family: JAK1 and TYK2 for 
type I and III IFNs; JAK1 and JAK2 for type II IFN. GAS, IFN-γ-activated site; IRF9, IFN regulatory factor 9; ISGF3, IFN-
stimulated gene factor 3, refers to the STAT1–STAT2–IRF9 complex; ISRE, IFN-stimulated response element; P, phosphate; 
STAT1/2, signal transducers and activators of transcription 1/2. 
The pivotal functions of interferons in immunity can be documented in the phenotype of 
STAT1-deficient mice. STAT1 is essential in both type I and type II interferons signaling 
pathways. The mice lacking STAT1 showed no overt developmental defects, and normal 
numbers of T cells, B cells and macrophages in thymus and spleen. But these mice displayed 
a complete lack of responsiveness to either IFN-α or IFN-γ and were highly sensitive to 
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infection by microbial pathogens and viruses (Durbin 1996; Meraz 1996). Similar phenotypes 
were also observed in IFN-γ deficient and IFN-γ receptor deficient mice (Huang 1993).  
The pleiotropic functions of interferons are executed by interferon-stimulated genes. 
Examples of these are class I and II MHC molecules. Up-regulation of MHC molecules can 
enhance the antigen presentation and promote the delivery of the signals from innate immune 
system to the adaptive immune system (Boehm 1997). Other molecules induced by 
interferons include adhesion molecules (ICAM1, VCAM1, et al) and chemokines which can 
recruit leukocytes and promote inflammation (Boehm 1997; Schroder 2004). Indeed, by 
inducing as many as one thousand genes, IFN-γ is extremely potent in activating the cytotoxic 
effector function among cells of innate and adaptive immunity including NK cells, dendritic 
cells, macrophages and T cells (Schroder 2004).  
1.3 Cell-autonomous immunity 
Cells, including immune and non-immune cells, can resist pathogen infection without the 
participation of other cells (neutrophils, cytotoxic T cells, NK cells, macrophages, et al) and 
molecules (antibodies, complements, et al) from innate and adaptive immune systems. This is 
termed cell-autonomous immunity, even though, in most cases, it is acquired upon induction 
of cytokines. IFN-γ is the most competent cytokine that can confer host cell autonomous 
resistance against viruses, pathogenic bacterium, and protozoa infection. Besides the IFN-γ-
induced genes introduced in chapter 1.2, the molecules responsible for cell-autonomous 
immunity include PKR, iNOS/NOS2, phox complex, NRAMP1, IDO, Mx, GBPs, and IRGs 
(Boehm 1997; Schroder 2004). In addtition to the well-understood universal resistance 
mechanisms like ROS/NO production and tryptophan depletion, it is surprising, but also 
interesting, to notice that several of these abundantly induced proteins are GTP binding 
proteins (GTPases), whose functions are largely unknown (Martens 2006).   
1.4 GTP binding proteins 
GTP binding proteins (GTPases) are a large family of hydrolase enzymes that can bind and 
hydrolyze GTP to GDP and/or GMP. These proteins participate in many cellular functions, 
such as translation (initiation, elongation, and release factors), signal transduction, cell 
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motility, intracellular transport, membrane trafficking, as well as cell-autonomous resistance 
against intracellular pathogens (Leipe 2002; Martens 2006). 
GTPases function as molecular switches, cycling between active GTP-bound form and 
inactive GDP-bound form (Figure 1.2)(Bourne 1990; Bourne 1991). Only GTP-bound form 
proteins are able to interact with a variety of effector proteins, by which cellular responses are 
executed. During the GTPase cycle, other proteins such as GEF, GAP and GDI can regulate 
the activity of the GTPases. GEFs (guanine-nucleotide exchange factors) induce the 
dissociation of GDP from GTPases and facilitate GTP-binding, and therefore activate 
GTPases. In contrast, GAPs (GTPase-activating proteins) accelerate GTP hydrolysis by 
GTPases, and therefore drive GTPases to the inactive GDP-bound form. GDIs (guanine-
nucleotide dissociation inhibitors) prevent the dissociation of GDP from GTPases and keep 
the enzymes in the inactive form (Vetter 2001). The GTP binding and hydrolysis takes place 
in the highly conserved nucleotide binding domain (G-domain) common to all GTPases. The 
G1-G5 motifs within the G-domain with more or less conserved sequences are the structural 
elements required for the nucleotide binding and hydrolysis (Leipe 2002).  
 
 
Figure 1.2 The GTPase cycle (from Martens 2006) 
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1.5 Interferon-inducible GTPases and dynamins 
Four GTPase families were found to be strongly induced by interferons, including Mx 
GTPases, p65 guanylate-binding proteins (GBPs), very large inducible GTPases (VLIGs) and 
p47 immunity-related GTPases (IRGs). All these GTPases share biochemical characteristics 
with the dynamins, as these proteins show GTP-dependent self-oligomerization and 
accelerated GTP hydrolysis upon oligomerization (Martens 2006).  
Dynamins are large GTPases with molecular weight of about 100 kDa. In addition to the 
conserved GTP-binding domain, classical dynamins have a pleckstrin homology (PH) domain 
involving phosphoinositide binding, a GTPase effector domain (GED) mediating self-
oligomerization, a proline rich domain (PRD) interacting with SH3 domain-containing 
proteins, as well as a middle domain. The function of dynamins was originally discovered as 
proteins crucial in the scission process of clathrin-coated vesicles from plasma membrane. 
Later investigations showed that dynamins are important in many cellular processes involving 
membranes such as vesicles trafficking, division of organelles and cytokinesis (Hinshaw 2000; 
Praefcke 2004).  
Among the interferon-inducible GTPases, the Mx family of dynamin homologs was the first 
to be found mediating cell-autonomous resistance against intracellular pathogens. The Mx1 
gene was originally mapped in lab mouse A2G strain for its resistance against influenza virus 
infection (Lindenmann 1963; Lindenmann 1964). Isolated macrophages from A2G mice 
showed cell-autonomous resistance against viral infection (Lindenmann 1978). Mx genes are 
present in all vertebrates and two members are found in human (MxA and MxB) and mouse 
(Mx1 and Mx2), respectively (Staeheli 1985; Goetschy 1989; Simon 1991). The anti-viral 
function of Mx proteins is accomplished, at least in part, by binding to the viral nucleocapsids. 
This interferes with intracellular trafficking and activity of viral polymerases, thus inhibiting 
replication of many RNA viruses including influenza and measles viruses (Haller 2007). Mx 
proteins are exclusively induced by type I interferons (Simon 1991). 
During the cellular responses to type II interferon (IFN-γ), p65 GBPs and p47 IRGS are the 
two dominant induced protein families (Boehm 1998). Type I interferons can also induce 
GBP and IRG proteins to a less extent (Nantais 1996; Bekpen 2005). The GBP family is 
conserved in verbebrates (Robertsen 2006). 10 members have been found in mice (mGBP1-
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10)(Degrandi 2007) and 7 in human (hGBP1-7)(Cheng 1991; Olszewski 2006). Even though 
GBPs are massively induced by interferons, only a weak anti-virus effect was reported in 
cultured cells using an over-expression system (Anderson 1999; Carter 2005). Surprisingly, 
no genetic analysis using gene targeted mice has yet been reported to link the functions of 
GBPs to immunity against intracellular pathogens (viruses and microbes). In addition, roles of 
GBPs in regulation of vasculogenesis by proinflammatory cytokines and IFN-mediated cell 
growth were suggested (Guenzi 2001; Gorbacheva 2002; Guenzi 2003). 
The third GTPase family induced by interferons is the VLIGs. These are the largest GTPases 
known so far, with molecular weight of about 280 kDa. The prototype of this family, VLIG-1, 
is massively induced by IFN-γ and to a less extent by IFN-β in vitro, and induced by Listeria 
monocytogenes infection in vivo. The G-domain of VLIGs is more closely related to IFN-
inducible GTPases mediating cell-autonomous resistance, especially Mx and GBP families, 
than to other GTPase families. Therefore, it has been suggested that VLIGs are a new family 
of resistance GTPases although no direct test for this idea has been reported (Klamp 2003). 
 
1.6 Immunity-related GTPases 
Unlike the poorly confirmed functions of GBP family in intracellular pathogen resistance, 
extensive experimental analyses have been reported describing the indispensable role of IRG 
family (p47 GTPases) in anti-microbial resistance in mice. A detailed introduction of the IRG 
family is therefore given here. 
1.6.1 IRG gene family 
An extensive and detailed analysis of the IRG gene family has been reported (Bekpen 2005). 
Homologous genes of IRGs are present in zebrafish, dogs, rats, mice and humans. In C57Bl/6 
mice strain, 21 genes have been found expressing 25 coding units. 4 genes are probably 
expressed as tandem proteins. Based on phylogenetic principles, IRG genes are further 
divided into Irga, Irgb, Irgc, Irgd and Irgm subfamilies. In the Irgm subfamily, the lysine in 
the canonical G1 nucleotide binding motif GX4GKS was replaced by methionine (GX4GMS). 
Most of the mouse genes have IRSE and/or GAS elements in their promoter regions. Irga6 
 8
                             Introduction  
has an additional liver specific promoter responsible for the expression of an alternative 
splicing form. The only exception in mice is Irgc, which lack both IRSE and GAS in its 
promoter. Instead a Sox-related element is present in the proximal promoter region. Irga 
subfamily is clustered on chromosome 18, whereas Irgb, Irgd and Irgm subfamilies are 
clustered on chromosome 11. Irgc is located alone in chromosome 7.  
In humans, only two IRG gene homologs have been found. Human IRGC encodes a full-
length IRG protein, which is highly homologous to mouse Irgc. They are more than 85% 
identical at nucleotide level and 90% at the amino acid level. The proximal promoter region 
of human IRGC is also largely conserved with that of mouse Irgc. Human IRGM encodes a 
considerably truncated protein that lacks the G5 motif in the classical nucleotide-binding 
domain, and is probably controlled by the LTR of an integrated ERV-9 repetitive element. 
IRGC and IRGM are located in human chromosome 19 and 5, respectively.    
1.6.2 Induction and expression of the IRG proteins 
Consistent with the promoter situations of IRG genes, most mouse IRG proteins are only 
expressed upon induction by interferons. Type II interferon (IFN-γ) is the most potent inducer 
of IRGs. Some reports describing IRGs induction in other circumstances, e.g. LPS, may 
reflect the secondary production of IFNs (Zerrahn 2002; Lapaque 2006). In addition to the 
massively-inductivity of Irga6 by IFNs, this member of IRGs has a high constitutive 
expression in the liver due to an alternative live specific promoter. The expression of Irgc and 
its human homologue IRGC are not IFN-regulatory and only constitutively expressed in the 
testis. Another member of IRGs in human, IRGM, was found to be expressed in cultured 
human cell lines Hela and GS293 and not subjected to interferons induction (Bekpen 2005; 
Rohde 2007).  
1.6.3 Structure and biochemical properties of the IRG proteins 
Irga6 is the only member of IRG proteins that has been successfully purified and whose 
biochemical properties have been systematically studies and crystal structure has been 
resolved to date. Recombinant Irga6 purified from E. coli crystallized as a dimer in the 
nucleotide-free and GDP-bound form (Uthaiah 2003). The Irga6 molecule is built from a Ras-
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like G-domain and a unique helical domain composed of N and C terminal helices. Based on 
sequence comparison and secondary structure prediction, Irga6 structure serves as a prototype 
for other IRG proteins (Figure 1.3)(Ghosh 2004). Recombinant Irga6 hydrolyzes GTP to GDP 
and form GTP-dependent oligomers. The hydrolysis activity is accelerated upon 
oligomerization with a maximum rate of 2 per minute per molecule of Irga6. Irga6 has a low 
nucleotide binding affinity (15µM for GTP and 1µM for GDP) compared to Ras family 
GTPases. Considering the celluar concentration of GDP and GTP (120µM and 330µM, 
respectively (Kleinecke 1979)), Irga6 is presumably in GDP-bound form in cells. The low 
affinities for nucleotide and cooperative hydrolysis upon oligomerization are properties 
shared also by GBPs, Mx proteins and dynamins, although GBPs and Mx proteins have 
similar affinities for GTP and GDP, while dynamins have a higher affinity for GTP (Uthaiah 
2003).  
Figure 1.3 Structure of Irga6 (from Ghosh 2004) 
 
Irga6 has an N-terminal myristoylation site MGxxxS and indeed, the myristoyl group 
contributes to the membrane association of Irga6 in cells (Martens 2004b). As a matter of fact, 
11 members in IRG family carry the amino-terminal myristoylation signal (Bekpen 2005). 
Recent data showed that myristoylated Irga6 purified from insect Sf9 cells hydrolyses GTP to 
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GDP and GMP (Papic 2007). This suggests that, in vivo, myristoylated IRG proteins may 
have strikingly different biochemical properties.  
No exogenous proteins have been found as regulators (GEF, GAP and GDI) of IRG proteins. 
As a self-activating GTPase, Irga6 functions as GAP (GTPase-activating protein) for itself.  
Recent data suggested that IRGM proteins interact with Irga6 and Irgb6 to prevent 
inappropriate activation (Hunn 2007). In this sense, IRGM proteins function like GDI proteins 
for other members of IRGs. A microtubule-motor binding protein, Hook3, has been found to 
interact directly with Irga6, and is likely an effector protein of Irga6 rather than a regulator 
(Kaiser 2004).  
Incomplete biochemical analyses of other IRG proteins were documented as well. Partially 
purified GST-Irgb6 and GST-Irgm3 fusion proteins have been shown to hydrolyze GTP to 
GDP (Taylor 1996; Carlow 1998). Weak GTPase activity was also reported for Irgm3 
immunoprecipitates from IFN-γ treated macrophages (Taylor 1996), and more than 90% of 
the bound nucleotide in priecipitated Irgm3 was GTP, independent of IFN-γ (Taylor 1997). 
This suggests that Irgm3 is mainly present in an active state in cells.  
 
1.6.4 Subcellular localization of IRG proteins 
IRG proteins associate with membranes to different degrees in IFN-γ induced cells. Irgm1 and 
Irgm3 have been found almost exclusively in a membrane compartment, while more than 
90% of Irgd is in the aqueous phase. Irgm2 has more membrane-bound form than cytosolic 
pool. Irga6 and Irgb6 partitioned roughly equally between membrane and cytosolic fractions 
(Martens 2004b). By immunofluorescence analyses, Irgm1 and Irgm2 localize to Golgi 
apparatus and Irgm3 is an ER-associated protein (Taylor 1997; Martens 2004a; Butcher 2005). 
Irga6 is targeted to ER, probably partially by a myristoyl group (Martens 2004b). IRGM 
proteins are organelle-targeted by a predicted α helix near the C-terminus, which, in case of 
Irgm1, shows amphipathic property (Martens 2004b; Martens 2006). The resting localizations 
of IRG proteins are largely independent of GTPase activity as GTP-binding defective mutants 
show similar subcellular distributions, wherever tested (Taylor 1997; Martens 2004b).  
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Irga6 and Irgb6 forms GTP-dependent aggregates when expressed in the absence of IFN-γ. 
Co-expression with IRGM proteins can restore the proper localization of Irga6 and Irgb6. 
Yeast 2-hybrid experiments also confirmed the direct interaction between different members 
of IRG family. Therefore, IRGM proteins can co-ordinate localization of other IRG protein 
family members (Martens 2006; Hunn 2007; Papic 2007). 
In cells involving pathogen infections or phagocytosis, IRG proteins are relocalized from 
resting compartments to the active membrane systems. Irgm1 is rapidly relocalized to F-actin-
rich plasma membrane ruffles associated with phagocytic cups in fibroblasts and 
macrophages (Martens 2004b). Irgm1 and Irgm3 have been found to associate with latex 
beads phagosomes rapidly after uptaken (Butcher 2005). In addition, Irgm1 has been co-
purified from mycobacterial phagosomes (MacMicking 2003). 5 members of IRGs have also 
been found on Toxoplasma gondii parasitophorous vacuole membrane shortly after the 
parasite invasion (Martens 2005). Compared to the nucleotide-binding independent of resting 
localization of IRG proteins, recruitment of IRGs to the T. gondii PVM requires the intact 
GTP binding motifs, suggesting a specific requirement for the nucleotide, presumably GTP, 
binding (Martens 2005; Hunn 2007). 
Recent publications showed that Irgm1 colocalizes with MDC and LC3 positive 
compartments, suggesting an association between Irgm1 and autophagosome (Gutierrez 2004; 
Singh 2006). The authors accordingly suggested that Irgm1 has a pro-autophagic function as a 
mechanism for mycobacteria elimination. However, in those publications, EGFP tagged 
Irgm1 was used, even though the influence on proper localization of Irgm1 by EGFP tagging 
was not investigated. In the present studies, we try to answer this question by in depth 
analyses.  
1.6.5 Involvement of the IRGs in resistance against intracellular pathogens in vivo and in 
vitro 
Studies of IRG-deficient mice and isolated cells have shown that members of IRG family are 
indispensable, in most cases also non-redundant, resistance factors against a wide range of 
intracellular bacteria and protozoal pathogens (Martens 2006; Taylor 2007). The published 
results are summarized in table 1.1. Generally, Irgm1-deficient mice lose resistance to all 
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microbes tested so far; Irgm3-deficient mice show decreased resistance to a smaller group of 
protozoa and only one of several tested bacteria; and Irgd-deficient and Irga6-deficient mice 
only show weakly decreased or normal resistance to pathogens tested. The IRG-dependent 
resistances have also been documented on the cell-autonomous level: Irgm1 and Irgm3 are 
required for IFN-γ induced control of T. gondii growth in macrophages (Butcher 2005); Irga6 
and Irgm3 in control of T. gondii in astrocytes (Halonen 2001; Martens 2005); Irgm1 in 
control of M. tuberculosis and T. cruzi in macrophages (MacMicking 2003; Santiago 2005); 
Irgm1, Irgm3 and Irgb10 in control of C. trachomatis in fibroblasts (Bernstein-Hanley 2006; 
Miyairi 2007; Coers Manuscripts in preparation). In these cases, there is a strong correlation 
between loss of resistance in mice and loss of IFN-γ-dependent control in cultured cells. This 
suggests that host cell-autonomous control of pathogens is a predominant function of IRG 
proteins. A recent report showed that a resistance/susceptibility polymorphism for C. 
trachomatis had been mapped to the region on mice chromosome 11 encoding Irgm3 and 
Irgb10. And the resistance/susceptibility was phenocopied at cellular levels as well 
(Bernstein-Hanley 2006; Miyairi 2007).  
The localization of IRG proteins to the pathogen-containing vacuoles in host cells suggests 
that they may execute their function by controlling vacuole processing. The proposed 
mechanisms include (i) lysosome fusion and/or acidification of the vacuole (MacMicking 
2003), (ii) vesiculation of the vacuolar membranes (Martens 2005; Ling 2006) and (iii) 
autophagy of the vacuolar contents (Gutierrez 2004; Ling 2006). Concerning the last 
hypothesis, most of studies so far have been performed in vitro and it remains to be confirmed 
whether autophagy can restrict intracellular pathogens in vivo by studying mice with targeted 
autophagy genes. 
As mentioned above, Mx and GBP GTPase families have potential anti-virus functions. A 
limited number of reports have addressed whether IRG family are also anti-viral. Ebola virus 
and mouse cytomegalovirus are controlled normally in Irgm3-deficient mouse (Taylor 2000). 
In addition, Irgm1 and Irgd are not required for resistance against MCMV (Collazo 2001). In 
vitro, a slightly elevated resistance to RNA virus VSV , but not DNA virus HSV, was found 
in L cells stably expressing Irgb6 (Carlow 1998). An even weaker effect was documented for 
Coxsackie virus in Hela cells expressing Irgm2 (Zhang 2003).  
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Table 1.1 Summary of evidences supporting roles of IRG proteins in host resistance (modified from Taylor 2007) 
Defined roles in host resistance IRG 
proteins In vivo  In cultured cells 
Possible mechanisms 
T. gondii (Collazo 2001) T. gondii (Butcher 2005) 
L. major (Santiago 2005) T. cruzi (Santiago 2005) 
T. cruzi (Santiago 2005)) M. tuberculosis (MacMicking 2003) 
L. monocytogenes (Collazo 2001) S. typhimurium (Henry 2007) 
M. tuberculosis (MacMicking 2003) C. trachomatis (Coers Manuscripts in 
preparation) 
M. avium (Feng 2004) 
Irgm1 
S. typhimurium (Henry 2007) 
 
-lysosomal fusion (MacMicking 2003; 
Deghmane 2007) 
-Haematopoiesis (Feng 2004; Santiago 
2005)  
-Impaired macrophages adhesion and 
motility (Henry 2007) 
-Autophagy (Gutierrez 2004; Singh 2006)  
Irgm2  C. psittaci (Henry 2007) C. psittaci (Miyairi 2007)  
T. gondii (Taylor 2000) T. gondii (Halonen 2001; Butcher 2005; 
Ling 2006) 
Irgm3 
L. major (Taylor 2007) C. Trachomatis (Bernstein-Hanley 
2006) 
-Vacuole vesiculation (Martens 2005; Ling 
2006) 
-lysosomal fusion (Ling 2006) 
-Autophagy (Ling 2006) 
 T. gondii (Martens 2005) Irga6 
 C. trachomatis (Nelson 2005) 
-Vacuole vesiculation (Martens 2005) 
-Membrane trafficking (Nelson 2005) 
Irgd T. gondii (chronic, (Collazo 2001)) T. cruzi (Koga 2006)  
Irgb10 C. psittaci (Miyairi 2007) C. trachomatis (Bernstein-Hanley 2006)  
 
1.7 Toxoplasma gondii infection as a model to study the functions of IRG proteins 
Infections by the protozoan parasite Toxoplasma gondii are widely prevalent in humans and 
animals worldwide. The definitive host of T. gondii is the cat, but the parasite can be carried 
by a vast majority of warm-blooded animals. Toxoplasmosis, the disease caused by T. gondii, 
is usually minor and self-limiting but can have serious or even fatal effects on an 
immunocompromised host or on a fetus whose mother is infected during pregnancy. Infection 
with this parasite proceeds in two phases in immunocompetent hosts (Luft 1992). During the 
acute phase its rapidly proliferating form, the tachyzoite, disseminates throughout the host; 
subsequently, during the chronic phase its dormant form, the bradyzoite, becomes established 
mainly in the central nervous system. This obligate parasite invades host cells, both 
haematopoietic and non-haematopoietic, by actively creating and entering into a unique non-
fusogenic membrane-bounded cytoplasmic compartment, the parasitophorous vacuole (Sibley 
2004). 
Once inside of the host, T. gondii is a potent stimulus for cell-mediated immunity, and IL-12-
dependent IFN-γ induction is vital for resistance to the parasite (Denkers 2003; Aliberti 2005). 
IL-12 is produced mainly by dendritic cells, neutrophils and macrophages and is the main 
cytokine to further stimulate the production of IFN-γ. T. gondii possesses two mechanisms for 
triggering IL-12. One is dependent upon adaptor protein MyD88 and involves Toll-like 
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receptors (Scanga 2002). The other is a more unusual pathway that involves CCR5 by a 
parasite cyclophilin molecule (Aliberti 2000; Aliberti 2003). T. gondii has several 
mechanisms to down-regulate immunity. Intracellular infection causes a blockage STAT1 
activation, therefore suppress the IFN-γ signaling (Luder 2001). In addition, intracellular 
parasite can subtlety modify host cell NFκB signaling pathway (Denkers 2003). NFκB is 
normally associated with transcription of proinflammatory mediators and resistance to 
infection. However, NFκB can also induce expression of several anti-apoptotic proteins, 
including inhibitor of apoptosis proteins (IAPs) and cFLIP, which behaves like a dominant-
negative form of caspase-8 (Karin 2002; Hayden 2004). It is well-established that T. gondii 
triggers rapid phosphorylation and degradation of the NFκB inhibitor IκB on parasitophorous 
vacuole membrane, which depends on both the host IKK and a parasite kinase activity, 
TgIKK (Molestina 2005b; Molestina 2005a). However, there are seemingly controversial 
reports concerning the activity of NFκB triggered by the parasites. Some groups reported that 
T. gondii-infected cells exhibit increased NFκB activation and gene expression (Gazzinelli 
1996; Blader 2001; Kim 2001), while several other groups reported that they are unable to 
observe NFκB activation despite infection-dependent increased IκB degradation (Butcher 
2001; Goebel 2001; Shapira 2005). This may reflect the ability of T. gondii to establish a 
beneficial niche for their long-term survival, as the modification of host cell physiology may 
differ in different host cell types and in different stages of infection. For example, one 
interesting publication reported that, in macrophages, activated form of NFκB fails to 
tranlocate into the host nucleus despite of IκB degradation. However, after 24hours, the 
blockade in NFκB nuclear import is lifted and tranlocation of activated of NFκB is observed 
(Butcher 2002). Notably there is no dispute regarding the induction of NFκB once infection is 
established and parasite replication is initiated.  
T. gondii infection can result in an anti-apoptotic state in host cells to facilitate the parasite 
intracellular growth. T. gondii infected cells are resistant to numerous, both intrinsic and 
extrinsic, apoptotic stimuli (Carmen 2007). In addition to the activation of NFκB-dependent 
pro-survival mechanisms mentioned above, T. gondii has been suggested to inhibit caspase-9 
activation through direct inhibition of apoptosome in in vitro reconstitution (Keller 2006) and 
by inhibiting the release of cytochrome c (Goebel 2001; Carmen 2006). The activation of the 
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PI3-kinase pathway has also been suggested as a mechanism of induction of anti-apoptotic 
state during the early stage of infection (Kim 2006a), as the NFκB activation is blocked 
during that stage. Extracellular pathways of suppressing host immunity by T. gondii infection 
have been reported as well. These involve the infection-induced host production of IL-10 and 
lipoxins that have potent IL-12 down-regulatory effects (Figure 1.4)(Aliberti 2002a; Aliberti 
2002b). Interestingly and surprisingly, no studies have been reported investigating how IFN-γ 
pretreatment influence the anti-apoptotic state conferred by T. gondii infection, considering 
IFN-γ is the most potent inducer for T. gondii resistance in vivo and in vitro.  
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Vesiculation and stripping of parasitophorous membrane have been observed in T. gondii 
infected astrocytes and macrophages (Martens 2005; Ling 2006). An autophagolysosomal 
process has been suggested in macrophages after stripping of T. gondii vacuolar membranes 
(Ling 2006). However, no lysosomal fusion has been observed in astrocytes (Martens 2005), 
and the question how naked parasites free in the cytosol are killed remains to be illustrated. 
Furthermore, although Irgm1 is indispensable for resistance against T. gondii in vivo, this 
protein is absent from T. gondii PVM indicating that IRGs may function in multiple layers of 
resistance (Butcher 2005; Martens 2005). 
1.8 Aims of this study 
Immunity-related GTPases (IRG) are powerful, non-redundant resistance factors against a 
variety of intracellular pathogens in mice. This is manifested by well-documented analyses 
using gene-targeted mice and cells for individual members of IRGs. Cell-autonomous control 
of pathogens is a predominant function of IRG proteins, although the exact mechanisms are 
still not known. Irgm1 is the most prominent member in IRG family for resistance as mice 
lacking this protein are susceptible to all bacterial and protozoal pathogens tested so far. 
Possible mechanisms have been suggested for functions of Irgm1 such as: (i) lysosome fusion 
and/or acidification of the vacuole (MacMicking 2003; Deghmane 2007), (ii) induction of 
autophagy (Gutierrez 2004; Singh 2006), (iii) regulation of the adhesion and motility of 
activated macrophages  (Henry 2007), (iv) negatively regulation of TLR4-triggered 
proinflammatory cytokine production and prevention of endotoxemia (Bafica 2007) and (v) 
regulation of haematopoiesis during chronic infection (Feng 2004; Santiago 2005).  
Irgm1 has been reported to localize to Golgi apparatus, ER and vesicular structures in resting 
cells. During phagocytosis it is rapidly relocalized to F-actin-rich plasma membrane ruffles 
associated with phagocytic cups in macrophages and fibroblasts (Martens 2004b). In the 
present study subcellular localization of Irgm1 and corresponding mechanisms are further 
investigated in depth. In addition, localization influenced by N and C terminal tag is analyzed, 
as proposed pro-autophagic function of Irgm1 is based on experiments using EGFP-tagged 
protein and correct subcellular localization was not confirmed. Furthermore, role of Irgm1 in 
cell-autonomous resistance to T. gondii infection in fibroblasts is studied. Finally, live cell 
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imaging system is established and employed to investigate the involvement of IRG proteins in 
resistance against T. gondii infection on a single cell level.  
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2. Material and Methods 
2.1 Reagents and Cells 
2.1.1 Chemicals, Reagents and Accessories 
All chemicals were purchased from Aldrich (Steinheim), Amersham-Pharmacia (Freiburg), 
Applichem (Darmstadt), Baker (Deventer, Netherlands), Boehringer Mannheim (Mannheim), 
Fluka (Neu-Ulm), GERBU (Gaiberg), Merck (Darmstadt), Pharma-Waldhof (Düsseldorf), 
Qiagen (Hilden), Riedel de Haen (Seelze), Roth (Karlsruhe), Serva (Heidelberg), Sigma-
Aldrich (Deisenhofen) or ICN biochemicals, Oxoid, (Hampshire UK). Developing and fixing 
solutions for Western Blot detection were from Amersham Pharmacia (Freiburg), Luminol 
from Sigma Aldrich (Deisenhofen), Coumaric acid from Fluka (Neu-Ulm). Deionised and 
sterile water (Seral TM) was used for all the buffers and solutions, Ultra pure water derived 
from Beta 75/delta UV/UF from USF Seral Reinstwassersysteme GmbH, (Baumbach) 
equipped with UV (185/254nm) and ultrafiltration (5000 kd cut off), or from Milli-Q-
Synthesis (Millipore). 
2.1.2 Equipments 
Centrifuges used were: Biofuge 13, Heraeus; Sigma 204; Sigma 3K10; Labofuge 400R, 
Heraeus; Sorvall RC-5B, Du Pont instruments; Optima TLX Ultracentrifuge, Beckmann and 
Avanti J-20 XP, Beckman. BioRAD Gel dryer, Model-583; BioRad Power pack 300 or 3000; 
electrophoresis chambers from FMC Bioproducts (Rockland Maine US); Gel Electrophoresis 
Chamber, Cambridge electrophoresis; Biorad Mini Protean II; PTC-100, MJ Research Inc.; 
ÄKTA P-920, OPC-900, Frac-950, Amersham; Centrifuge tubes 15ml, TPP Switzerland; 
50ml Falcon, BectonDickenson; Zeiss Axioplan II microscope equipped with AxioCam MRm 
camera (Zeiss). Zeiss Axiovert 200M motorized microscope equipped with AxioCam MRm 
camera (Zeiss). ELISA reader (Vmax, Molecular Devices) 
 
 19
                            Material and Methods  
2.1.3 Materials 
Sterile filters FP 030/3 0,2 µm and ME 24 0,2 µm (Schleicher und Schüll, Dassel); 
Nitrocellulose transfer membrane PROTRAN (Schleicher und Schüll, Dassel); 3MM 
Whatmann Paper (purchased via LaboMedic); 100 Sterican 0,50 x 16mm hypodermic needles 
(Braun AG, Melsungen); 0.2µm and 0.45µm sterile filters (Schleicher und Schuell, Dassel); 
X-OMAT LS and AR X-ray films, Kodak. All plastic ware for cell culture was from Sarstedt 
(Nümbrecht) or Greiner (Solingen). 
2.1.4 Enzymes and Proteins 
Restriction enzymes (New England Biolabs); Pyrococcus furiosus (Pfu) DNA Polymerase 
(Promega, Mannheim); T4 DNA ligase (New England Biolabs); RNase A (Sigma); shrimp 
alkaline phosphatase (SAP) (USB, Amersham); PageRulerTM Prestained Protein Ladder 
(Fermentas); PageRulerTM Protein Ladder (Fermentas); SigmaMarkerTM Wide Range 
(Sigma); GeneRulerTM DNA Ladder Mix (Fermentas). 
2.1.5 Kits 
Plasmid Maxi and Midi kit (Qiagen, Hilden), 
Terminator-cycle Sequencing kit version 3 (ABI), 
QuikChange TM Site directed mutagenesis kit (Stratagen), 
Rapid PCR product purification Kit (Roche, Mannheim), 
2.1.6 Vectors and constructs used in the present study 
pGW1H (British Biotech),  
pEGFP-C3, pEGFP-N3 (Clontech), 
pmDsRed-C3, pmDsRed-N3, pCherry-C3, pCherry-N3 
pF25: gift from Dr. Gregory A. Taylor, Duke Univeristy, coding for the N-terminally EGFP-
tagged Irgm1 (Irgm1-EGFP). 
EGFP-Irgm1, EGFP-Irgm1 αK, EGFP-LC3, Irga6-ctag1-EGFP 
 
 20
                            Material and Methods  
2.1.7 Cell lines, bacterial and protozoan strains 
Murine embryonic fibroblasts (MEFs) derived from C57/BL6 mice, L929 (CCL-1) and gs3T3 
(Invitrogen) mouse fibroblasts were cultured in DMEM supplemented with 10% FCS 
(Biochrom AG, Berlin), 2 mM L-Glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin and 
100 µg/ml streptomycin, all from Gibco BRL. Human foreskin fibroblasts (Hs27, ATCC 
CRL-1634) were cultured in IMDM supplemented with 5% FCS and 2mM L-glutamine. 
Sterile trypsin/EDTA solution in PBS (10x trypsin/EDTA solution: 0.05% (w/v) trypsin 
(1:250, Gibco BRL)/17 mM EDTA/145 mM NaCl)) was used to detach adherent cells from 
culture flasks.  
Escherichia coli DH5α: 80dlacZ ∆Μ15, recA1, endA1, gyrA96, thi-1, hsdR17 (rB-, mB+),             
supE44, relA1, deoR, ∆(lacZYA-argF)U169 
Toxoplasma gondii:    Type II strain ME49, Type I strain RH-YFP 
2.1.8 Media 
Luria Bertani (LB) medium:  
10 g bacto tryptone, 5 g yeast extract, 10 g NaCl, destilled water 1L 
 
LB plate medium: 
10 g bacto tryptone, 5 g yeast extract, 10 g NaCl, 15 g agar, destilled water 1L 
 
IMDM (Iscove’s Modified Dulbecco’s Medium) supplemented with 10% FCS (Biochrom AG, 
Berlin), 2 mM L-glutamine, 1 mM sodium pyruvate, 1x non-essencial amino acids, 100 U/ml 
penicillin, 100 µg/ml streptomycin (all from Gibco BRL) 
 
DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 10% FCS (Biochrom AG, 
Berlin), 2 mM L-glutamine, 1 mM sodium pyruvate, 1x non-essencial amino acids, 100 U/ml 
penicillin, 100 µg/ml streptomycin (all from Gibco BRL) 
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2.1.9 Serological reagents 
Primary antibodies and antisera 
Name Immunogen Species Concentration Dilution Origin 
P20 N-terminus peptide 
of Irgm1 
Goat 
polyclonal 
0.2 mg/ml IF: 1:100 Santa Cruz 
Sc-11074 
1B2 Irgm1 Mouse 
monoclonal 
 IF: undiluted 
supernatant from 
hybridoma cell culture  
Dr. Gregory Taylor 
Duke University 
165 Recombinant Irga6 Rabbit 
polyclonal 
1-3 mg/ml WB: 1:25000 
IF: 1:8000 
 
H53 N-terminus peptide 
of Irgm2 
Rabbit 
polyclonal 
 IF: 1:1000  
αIGTP 
clone 7 
aa 283-423 of Irgm3  Mouse 
monoclonal 
0.25 mg/ml WB: 1:2000 
 
BD Transduction 
laboratories 
A20 
 
N-terminal peptide of 
Irgb6 
Goat 
polyclonal 
0.2 mg/ml WB: 1:500 
IF: 1:100 
Santa Cruz 
sc11079 
GM130 
 
C-terminus of rat 
GM130 
Mouse 
monoclonal 
IgG1 
 IF: 1:1000 
WB: 1:250 
BD transduction Lab.  
610822 
S-20  C-terminus peptide 
from rat TGN38 
origin 
Goat 
polyclonal 
0.2 mg/ml IF: 1:100 Santa Cruz 
Sc-27681 
CI-M6PR 
antibody 
CI-M6PR Rabbit 
polyclonal 
 IF: 1:100 Albert Hass, Bonn 
1D4B Mouse LAMP1 Rat monoclonal  IF: 1:1000 DSHB, Iowa 
SPA-865 Peptide from canine 
calnexin aa 50-68 
Rabbit 
polyclonal 
 WB: 1:10000 
IF: 1:200 
Stressgen  
GRA7 GRA7 Mouse 
monoclonal 
 IF: 1:1000 Gaby Reichmann 
Düsseldorf 
Cytochrome 
C antibody 
Rat  
cytochrome c 
Mouse 
monoclonal 
0.5 mg/ml IF: 1:1000 BD PharMingen 
556432 
Clone: 6H2.B4 
HMGB1 
antibody 
aa150 to the C-
terminus of human 
HMGB1 
Rabbit 
polyclonal 
0.5 mg/ml WB: 2µg/ml Abcam 
ab18256 
Cleaved 
Caspase-3  
antibody 
N-terminal peptide 
adjacent to Asp175 
of human Caspase-3 
Rabbit 
polyclonal 
 WB: 1:1000 Cell signaling 
Technology, Inc. 
#9661 
PARP 
antibody 
Peptide 
corresponding to the 
caspase cleavage site 
Rabbit 
polyclonal 
 WB: 1:1000 Cell signaling 
Technology, Inc. 
#9542 
Secondary antibodies and antisera 
The following secondary immunoreagents were used: goat anti-mouse Alexa 488 and 546, 
goat anti-rabbit Alexa 488 and 546, goat anti-rat Alexa 555, donkey anti-rat Alexa 488, 
donkey anti-goat Alexa 350, 488, 546 and 647, donkey anti-mouse Alexa 488, 555 and 647, 
donkey anti-rabbit Alexa 488, 555 and 647 (Molecular Probes; all used 1:1000 for 
immunofluorescence). Donkey anti-rabbit HRP (Amersham), donkey anti-goat HRP (Santa 
Cruz) and goat anti-mouse HRP (PIERCE) (all horse radish peroxidase (HRP)-coupled sera 
were used 1:5000 for immunodetection of Western blots). 4',6-Diamidine-2'-phenylindole 
dihydrochloride (DAPI, Invitrogen) was used for nuclear counterstaining at a final 
concentration of 0.5 µg/ml. 
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2.1.10 Peptides 
The following peptides are synthesized by JPT Peptide Technologies GmbH, Berlin 
Irgm1 αK:                H-SKLRLMTCAIVNAFFRLLRFLPCVCC-OH 
Irgm1 αK ins362E:  H-SKLRLMTCAIVNAEFFRLLRFLPCVCC-OH 
Irgm2 αK:                Biotin-SKVLARLYRTGTRVGSIGFDYMKCCFTSH-OH 
Irgm3 αK:                Biotin-SKMMCFAVNKFLRLLESSWWYGLWNVVTR-OH 
The Irgm1 αK and Irgm1 αK ins362E peptides are biotinylated at the second residue Lysine. 
2.2 Molecular Biology 
2.2.1 Agarose gel electrophoresis 
DNA was analysed by agarose gel electrophoresis (1x TAE; 0.04 M Tris, 0.5 mM EDTA, pH 
adjusted to 7.5 with acetic acid) The DNA was stained with ethidium bromide (0.3 µg/ml), a 
fluorescent dye which intercalates between nucleotide bases, and the migration of the DNA 
molecules was visualized by using bromophenol blue. 
2.2.2 Generation of the expression constructs 
The following primers were used to generate the Irgm1 S90N mutant in EGFP-Irgm1 and 
Irgm1-EGFP (pF25) constructs. 
Forward: 5´- gggactctggcaatggcatgaattctttcatcaatgcacttcg -3´ 
Reverse: 5´- cgaagtgcattgatgaaagaattcatgccattgccagagtccc -3´ 
 
Following mutations were introduced into EGFP-Irgm1 αK construct using the listed primers: 
L366A   Forward:  5´-gcaattgtgaatgctttcttccgtttggcgagatttctccc -3´ 
Reverse:  5´-cgttaacacttacgaaagaaggcaaaccgctctaaagaggg -3´ 
L365A   Forward: 5´-gcaattgtgaatgctttcttccgtgcgttgagatttctccc -3´ 
Reverse: 5´-cgttaacacttacgaaagaaggcacgcaactctaaagaggg -3´ 
R367A   Forward: 5´-gcaattgtgaatgctttcttccgtttgttggcatttctcccatgc -3´ 
Reverse: 5´-cgttaacacttacgaaagaaggcaaacaaccgtaaagagggtacg -3´ 
R364A   Forward: 5´-gcaattgtgaatgctttcttcgctttgttgagatttctccc -3´ 
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Reverse: 5´-cgttaacacttacgaaagaagcgaaacaactctaaagaggg -3´ 
F363A    Forward: 5´-gcaattgtgaatgctttcgcccgtttgttgagatttctccc -3´ 
Reverse: 5´-cgttaacacttacgaaagcgggcaaacaactctaaagaggg -3´ 
F362A    Forward: 5´-gcaattgtgaatgcagcattccgtttgttgagatttctccc -3´ 
Reverse: 5´-cgttaacacttacgtcgtaaggcaaacaactctaaagaggg -3´ 
N360A   Forward: 5´-catgtgcaattgtggcagcattcttccg -3´ 
Reverse: 5´-gtacacgttaacaccgtcgtaagaaggc -3´ 
L365A, L366A: Forward: 5´- gcaattgtgaatgctttcttccgtgcggcgagatttctccc -3´ 
Reverse: 5´-cgttaacacttacgaaagaaggcacgccgctctaaagaggg -3´ 
F362A, F363A Forward :5´- gcaattgtgaatgcagcagcccgtttgttgagatttctccc -3´ 
Reverse: 5´-cgttaacacttacgtcgtcgggcaaacaactctaaagaggg -3´         
N360A, R364A, R367A  Forward: 5´- gtgcaattgtggctgcattcttcgctttgttggcatttctcccatgcg -3´ 
Reverse: 5´-cacgttaacaccgacgtaagaagcgaaacaaccgtaaagagggtacgc -3´ 
N360A, R364A Forward: 5´- gtgcaattgtggctgcattcttcgctttgttgagatttctccc -3´ 
Reverse: 5´-cacgttaacaccgacgtaagaagcgaaacaactctaaagaggg -3´ 
R364A, R367A  Forward: 5´-gcaattgtgaatgctttcttcgctttgttggcatttctcccatgcg -3´ 
Reverse: 5´-cgttaacacttacgaaagaagcgaaacaaccgtaaagagggtacgc -3´ 
F362A, F363A, L365A, L366A 
Forward:  5´- gcaattgtgaatgcagcagcccgtgcggcgagatttctcccatgcg -3´  
Reverse:  5´-cgttaacacttacgtcgtcgggcacgccgctctaaagagggtacgc -3´ 
 
pmDsRed-C3, pmDsRed-N3, pCherry-C3, pCherry-N3 constructs were made by 
amplification of mDeRed or mCherry sequences from pDsRed-Monomer-N In-Fusion 
(Clontech) or mCherry-pRsetB (gift from Tsien 2005), respectively, by using the following 
primers. pmDsRed-C3 and pCherry-C3 PCR products were digested with NheI and ScaI, and 
ligated into the  NheI/ScaI digested pEGFP-C3 vector. pmDsRed-N3 and pCherry-N3 PCR 
products were digested with BamHI and NotI, and ligated into the BamHI/NotI digested 
pEGFP-N3 vector. 
pmDsRed-C3  Forward:  5´- ccccccccc gctagc gccacc atg gacaacaccgaggacgtcat -3´ 
Reverse:  5´-ccccccccc agtact t ctgggagccggagtggcgggc -3´ 
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pmDsRed-N3  Forward:  5´- ccccccccc ggatcc atg gacaacaccgaggacgtcat -3´ 
Reverse:  5´-ccccccccc gcggccgc ctactgggagccggagtggcgggc -3´ 
pCherry-C3  Forward:  5´- ccccccccc gctagc gccacc atg gtgagcaagggcgaggagga -3´                    
Reverse:  5´-ccccccccc agtact t cttgtacagctcgtccatgc -3´ 
pCherry-N3  Forward:  5´-ccccccccc ggatcc atg gtgagcaagggcgaggagga -3´ 
Reverse:  5´-ccccccccc gcggccgc ctacttgtacagctcgtccatgc -3´ 
2.2.3 Cloning of PCR amplification products 
Amplified PCR products were purified using the rapid PCR purification Kit (Roche) and 
eluted with 100 µl 10mM Tris, pH 8.5. DNA yield was monitored by agarose gel 
electrophoresis and DNA fragments were digested with the appropriate restriction 
endonuclease (New England Biolabs) according to the suppliers’ protocol. Restriction 
enzymes were used at a 5-10 fold over-digestion. Following restriction, DNA fragments were 
again column purified using the rapid PCR purification Kit (Roche) and DNA yield was 
monitored by agarose gel electrophoresis. 
2.2.4 Purification of DNA fragments from agarose gels 
DNA fragments were loaded on agarose gels of the suitable percentage after incubation with 
appropriate restriction endonucleases. After proper separation of the fragments, DNA was 
visualized under a low energy UV source and cut out of the gel using a clean blade. DNA 
fragments were eluted from the gel with the rapid PCR purification Kit (Roche) according to 
the manufactures protocol. Purity and yield of the DNA was determined by agarose gel 
electrophoresis and UV spectroscopy. 
2.2.5 Ligation 
The appropriate cloning vector was cut with the respective restriction enzyme(s) (10 U/ 1 µg 
DNA) for 1 h under according to the restriction enzyme suppliers’ protocol. After the first 
hour the same amount of restriction enzyme and 0.1 U of shrimp alkaline phosphatase were 
added to the reaction followed by 1.5 h incubation. Following restriction, DNA fragments 
were column purified using the rapid PCR purification Kit (Roche) and DNA yield was 
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monitored by agarose gel electrophoresis. Vector and the appropriate cut insert were mixed at 
a ratio of 1:3 and ligated with T4-DNA ligase in a total volume of 10 µl at 16°C over-night 
according to the manufactures protocol. As control, the same reaction without insert was 
carried out which should not yield any colonies after transformation into competent DH5α. 
2.2.6 Preparation of competent cells 
A single colony from a particular E .coli strain was grown over-night in 2 ml LB medium 
with 0.02 M MgSO4/ 0.01 M KCl with vigorous shaking (~300 rpm). It was diluted 1:10 into 
fresh medium with the same constituents and grown for 90 min, at 37°C to an OD600 of 0.45. 
Cultures were incubated on ice for 10 min after which the cells were pelleted by 
centrifugation at 6000 rpm at 4°C for 5 min. Cells were resuspended in TFB I (30 ml/ 100 ml 
culture), incubated 5 min on ice, pelleted again by centrifugation at 6000 rpm at 4°C for 5 min 
and finally resuspended in TFB II (4 ml per 100 ml culture). 100 µl aliquots of the competent 
bacteria were frozen at –80°C. 
Composition of the buffers: 
TFB I (30 mM KOAc/50 mM MnCl2/100 mM RbCl2/10 mM CaCl2/15% w/v glycerin, pH 5.8) 
TFBII (10 mM MOPS, pH 7.5/ 75 mM CaCl2/ 100 mM RbCl2/ 15% w/v glycerin) 
Both the solutions were sterilized and stored at 4°C. 
2.2.7 Transformation of competent bacteria 
100 µl of competent bacteria were thawed on ice and gently mixed 3-4 times. 5 µl of the 
ligation reaction was added to the cells followed by incubation for 20 min on ice Cells were 
then heat-shocked for 45 sec at 42°C followed by a further incubation on ice for 2 min. 
Antibiotic free LB medium was added to a total volume of 1 ml and cells were rolled at 37°C 
for 1 h. The culture was spun at 9000 rpm for 2 min and 800 µl of the supernatant was 
removed. The cell pellet was resuspended in the remaining 200 µl medium in the 1.5 ml 
reaction tube and plated on a LB agar plate supplemented with the appropriate antibiotics. 
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2.2.8 Plasmid isolation 
For screening a large number of cultures for clones containing the desired insert, 4 ml LB 
cultures with the appropriate antibiotics were inoculated with single colonies picked from a 
ligation plate and grown over-night at 37°C, 250 rpm. All following steps were performed at 
room temperature. 1.5 ml of the cultures was transferred into a 1.5 ml reaction tube and 
pelleted by centrifugation at 23000 g for 5 min. The supernatant was discarded and pellet 
resuspended in 100 µl P1 (50 mM Tris, pH 8.0/ 10 mM EDTA/ 100µg/ml RNase A). After 
addition of 100 µl P2 (200mM NaOH/ 1% SDS) the reaction was gently mixed and incubated 
for 5 min. 140 µl of P3 (3M potassium acetate, pH 5.5) was added and the reaction was spun 
for 15 min at 23000 g. The supernatant (~340 µl) was transferred into a new tube and 700 µl 
of 100% ethanol was added. After mixing, the reaction was spun for 15 min at 23000 g and 
the supernatant was removed. The pellet was washed by addition of 700 µl of 70% ethanol 
and spun at 23000 g. After removal of the supernatant the pellet was air-dried and 
resuspended in 50 µl 10mM Tris pH 8.0. 5 µl of the plasmid preparation was cut with the 
appropriate restriction enzyme(s) in a total volume of 50 µl for 1 h and 10 µl of the reactions 
were subjected to agarose gel electrophoresis to identify insert-containing clones. 
For preparation of large amounts of plasmid, the Qiagen Midi and Maxi Plasmid Preparation 
Kits were used according to the manufactures instructions. 
2.2.9 Determination of the concentration of DNA 
The concentration of DNA was measured using a spectrophotometer at 260 nm. The purity of 
the DNA solution was determined using the ratio of OD readings at 260 nm and 280 nm. Pure 
preparations of DNA have an OD260/OD280 ratio of 1.8. The concentration was calculated 
according to the following equation. c = A260 x 50 µg/ml x dilution factor. 
2.2.10 Site directed mutagenesis 
Site directed mutagenesis was carried out using a modified protocol supplied with “Quik-
ChangeTM XL Site-Directed Mutagenesis” Kit from Stratagene. The amplification was carried 
out using 20 ng plasmid as template, 125 ng of the sense and antisense oligonucleotide as 
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primers and 2.5 U of Pfu-polymerase (Promega) in a total volume of 50 µl. The following 
program was used: 1. 95°C, 30 sec; 2. 95°C, 30 sec; 3. 55°C, 60 sec; 4. 68°C, 15 to 20 min 
(back to step 2., 15 to 18 times); 5. 68°C, 15 min. After amplification 1 µl DpnI (20 U, New 
England Biolabs) was added to the reaction and incubated for 1.5 h at 37°C. 5 µl of the 
reaction was used to transform 200 µl competent DH5α. As control the whole procedure was 
carried out without addition of Pfu-polymerase. Ideally no colonies are found on the final LB 
agar plate for the control reaction. 
2.2.11 DNA Sequencing 
All constructs generated were verified by sequencing. DNA was sequenced using the ABI 
PrismR BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (PE Applied 
Biosystems), using fluorescently labeled dideoxynucleotides based on the dideoxy-chain 
termination. Template DNA (0.5 µg), the respective primer (10 pmole) and 2 µl Big DyeTM 
terminator ready reaction mix (ABI) were combined in a total volume of 10 µl and the 
sequencing reaction was carried out as follows: 25x (96°C, 30 sec; 50°C, 15 sec; 60°C, 4 min). 
Sequencing was done on an automated sequencer (ABI 373A). 
 
2.3 Cell biology 
2.3.1 Transfection 
Cells were transiently transfected for 24 h at 37°C using FuGENE 6 Transfection Reagent 
(Roche) according to the manufacturer’s protocol. DNA (µg): FuGENE6 (µl) ratio was 
always 1:3. For transfection of cells in 6 well plates or in 60 mm dish 1 µg or 2 µg of DNA 
was used respectively. 
2.3.2 Transferrin uptaking experiments 
Cells were grown on coverslips and starved for 1 hour in the FCS-free medium. To label the 
early endosomes, Alexa-546 labeled human Transferrin (Molecular Probes) was then diluted 
to the final concentration of 5 µg/ml into the FCS-free medium, and cells were incubated at 
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37°C, 7.5% CO2 for 5 minutes. Cells were then fixed with ice-cold 3% PFA in PBS for 20 
minutes.  
To label the recycling endosomes, the cells were incubated with FCS-free medium with 
diluted transferrin for 10 minutes after starvation, then washed with ice-cold PBS for 3 times. 
The full medium was added afterwards and the cells were incubated at 37°C, 7.5% CO2 for 30 
minutes. Finally cells were fixed with ice-cold 3% PFA in PBS for 20 minutes followed by 
three times washing with PBS and subjected to the immunofluorescence staining.  
2.3.3 Lysotracker loading experiments 
Lysotracker Red DND-99 (Molecular Probes) was diluted to a final concentration of 50 nM in 
the full medium and the cells were incubated at 37°C, 7.5% CO2 for 20 minutes. Cells were 
then fixed with ice-cold 3% PFA in PBS for 20 minutes followed by three times washing with 
PBS and subjected to the immunofluorescence staining. 
2.3.4 Latex beads phagocytosis experiments 
MEFs were grown on the coverslips, treated with 200 U/ml IFN-γ and/or transfected with 
indicated constructs for 24 hours. During the IFN-γ-treatment and/or transfection procedure, 2 
µm carboxylated latex beads (Polysciences) were added to the culture at a dilution of 1:1000, 
and the cells were incubated with the latex beads at 37°C overnight. The latex beads were 
extensively phagocytosed by the MEFs through unidentified receptors. Finally the cells were 
fixed with 3% paraformaldehyde (PFA) for 20 minutes at room temperature and subjected to 
the immunofluorescence staining. 
2.3.5 Immunocytochemistry 
Cells were grown on coverslips, fixed with PBS/ 3% paraformaldehyde (PFA) for 20 min and 
subsequently washed three times with PBS. Cells were permeabilized with PBS/0.1% saponin 
(washing buffer) followed by a blocking step with PBS/0.1% saponin/1% BSA (fractionV) 
(blocking buffer) for 1 hour. Coverslips were incubated with primary antibodies (diluted in 
blocking buffer) in a humid chamber for 1 h at RT and subsequently washed 3x 5 min with 
washing buffer. Incubation with secondary antibodies was done as described for primary 
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antibodies for 30 min at RT and washed 3x as described above. Coverslips were mounted on 
slides with ProLong® Gold antifade reagent (Invitrogen), sealed with nail polish and cleaned 
with deionized water. DAPI, used to stain DNA (300 nM), was added to the secondary 
antibody solution. Images were taken with a Zeiss Axioplan II fluorescence microscope 
equipped with an AxioCam MRm camera (Zeiss). Images were processed with Axiovision 4.6 
software (Zeiss). 
2.3.6 Peptide-streptavidin complex experiments 
The peptides were dissolved in 10mM NaAc pH4.5 buffer with 10mM TCEP as reducing 
agent and stored at -80°C with a stock concentration of ~100 µM. The absolute absorbance of 
the Irgm1 αK peptide at 230 nm in the dissolving buffer is ~0.46/100 µM.  
The peptide-streptavidin complex was made in the blocking buffer used in the 
immunofluorescence staining (PBS pH7.4/0.1% saponin/1% BSA with additional 2 mM 
DTT). The C3-labelled streptavidin (Sigma, S6402) was first diluted in the blocking buffer to 
a final concentration of 20 µg/ml (0.33 µM). The peptide stocking solution was then added to 
the streptavidin solution with a titration from 4:1 to 50:1 molar ratio (peptide to streptavidin). 
The optimum ratio was experimentally determined based on the staining signals (8 µM 
peptide in the Figure 3.18). The peptide-streptavidin solution was well-mixed and then spun 
down at 45.000 rpm for 30 minutes. The supernatant was recovered and antibodies against 
indicated proteins were added. This solution was used as the primary antibody in the 
immunofluorescence staining, and was incubated with the PFA-fixed saponin permeabilized 
cells at 37°C for 1 hour. The peptide-streptavidin images were obtained through Cy3 channel 
in the Zeiss Axioplan II fluorescence microscope. 
2.3.7 In vitro passage and infection of Toxoplasma gondii 
Tachyzoites from T. gondii strains ME49 and RH-YFP were maintained by serial passage in 
confluent monolayer of human foreskin fibroblasts (HS27, ATCC number CRL-1634). RH-
YFP parasites were propagated in presence of Chloramphenicol (3.2 µg/ml, Sigma-Aldrich) to 
maintain the stably integrated YFP expression plasmid containing a chloramphenicol 
acetyltransferase selection marker. 
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The T. gondii replicate intracellularly and egress from their host cells approximately 3 days 
later. Extracellular parasites were harvested from the supernatant and purified from host cell 
debris by differential centrifugation (5 minutes at 100g, 15 minutes at 500g). The parasites 
were resuspended in medium, counted using a Neubauer chamber and immediately used for 
the infection of the host cells.   
2.3.8 Live cell imaging 
All the live cell imaging experiments were performed in µ-slide I (ibidi, München). Cells 
were incubated in phenol-red-free DMEM supplemented with 10% FCS, 20 mM HEPES pH 
7.4, 2 mM L-glutamine, 1 mM sodium pyruvate, 1x non-essential amino acids, 100 U/ml 
penicillin, and 100 µg/ml streptomycin. 1×105/100 µl MEFs were seeded in the channel of the 
µ-slide I and 500 µl medium was then added to each of the reservoirs. For the transfection 
experiments, 2 µg DNA/6 µl Fugene6 in 100 µl FCS-free medium was prepared and 50 µl of 
the transfection reagent was added to the channel of one µ-slide I. The cells were 
simultaneously stimulated with 200 U/ml IFN-γ for 24 hours. After infection with T. gondii, 
the cells were observed under the Zeiss Axiovert 200M motorized microscope with the 
objective EC “Plan-Neofluar” 40×/1.30 Oil Ph3 (Zeiss). The time-lapse images were obtained 
and processed by Axiovision 4.6 software (Zeiss).  
Phosphatidylserine exposure were detected by adding 1% (v/v) annexin-V-Alexa555 
(Molecular Probes) with 2.5 mM CaCl2 into the medium. Propidium iodide (0.4 mg/ml) was 
added into the medium to detect the loss of cell plasma membrane integrity.  
2.3.9 Quantification of IRG signals on T. gondii parasitophorous vacuoles 
The signal intensities for the specific IRG proteins on the T. gondii parasitophorous vacuoles 
were quantified using the ImageJ software (Wayne Rasband, NIH). The images are processed 
in 16-bit (Zeiss Axioplan II microscope) or 12 bit (Zeiss Axiovert 200M motorized 
microscope) gray-scale TIFF format. Two intensity profiles orthogonal to each other were 
generated per vacuole followed by subtraction of the background values. The average of the 4 
peak values was obtained for each vacuole. The average pixel intensity of each vacuole was 
plotted for each IRG protein in a scatter plot using Excel (Microsoft). 
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2.3.10 Cell viability assay 
7500 cells/well MEFs were seeded into 96-well plates and treated with IFNγ or control 
condition for 24 hours. The cells were then infected with T. gondii avirulent strain ME49 or 
virulent stain RH-YFP for 8 or 20 hours. Thereafter, the viable cells were quantified by the 
CellTiter 96 AQueous non-radioactive cell proliferation assay (Promega) according to the 
manufactorer’s instructions. The absorption of the bio-reduced form (formazan) of a substrate 
(MTS) generated by metabolically active cells during incubation at 37°C for 2-4 hours was 
measured in an ELISA reader (Molecular Devices) at 490 nm. The quantity of formazan 
product is directly proportional to the number of living cells in the culture. 
2.3.11 Western blotting 
After SDS-PAGE, proteins were transferred to nitrocellulose transfer membranes (Schleicher 
&Schuell) by electroblotting. The gel was placed in contact to a nitrocellulose transfer 
membrane, and was sandwiched between four sheets of 3 mm Whatmann paper, two porous 
pads, and two plastic supports on either side, soaked in a transfer buffer containing 25 mM 
Tris/ 190 mM glycine. The sandwich was then placed between platinum plate electrodes, with 
the nitrocellulose membrane facing the anode, and the transfer was carried out at RT for 1 h 
with a current of 0.5 V. Ponceau S staining was used to locate proteins (0.1%(w/v) Ponceau S 
(Sigma) in 5% (v/v) acetic acid) after Western blotting. Membranes were blocked with PBS/ 
5% milk powder/ 0.1% Tween 20 or Western Blotting Blocking Reagent (Roche) at room 
temperature for 1 h or over-night at 4°C. Antisera/ antibodies were diluted in PBS/ 5% FCS/ 
0.1% Tween 20 or PBS/ 5% Western Blotting Blocking Reagent. Bands were visualized with 
enhanced chemiluminescence (ECL) substrate. 
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3.1 Irgm1 localizes to Golgi apparatus and late endocytic/lysosomal compartments.  
Irgm1 (LRG-47) was reported to be exclusively in membrane-bound form and localized to the 
Golgi apparatus in L929 fibroblasts, TIB-75 hepatocytes and Raw 264.7 macrophages. This 
localization is mediated by an amphipathic helix near the C-terminus (Martens 2004b). It was 
also noted that in addition to the Golgi localization, there is a distributed granular signal 
throughout the cell periphery, of which the subcellular localization remained to be identified. 
In order to investigate in detail the intracellular distribution of Irgm1, C57BL/6 embryonic 
fibroblasts were used in the present study, which is microscopically favorable. Compared to 
L929 cells or macrophages that are morphologically round and small (~25µm), MEFs are 
much larger (50-100µm) and spread flat on the cover slips. In IFN-γ treated MEFs, both goat 
polyclonal anti-Irgm1 antiserum P20 and mouse monoclonal anti-Irgm1 antibody 1B2 gave a 
focused perinuclear signal and additional distributed granular signals. The perinuclear signal 
accurately overlaps with both cis-Golgi matrix protein GM130 and trans-Golgi/trans-Golgi 
network protein TGN38 (Figure 3.1, a-f). Less accurate colocalization was seen with cation-
independent mannose 6 phosphate receptor (CI-M6PR), which is predominantly distributed in 
the late endosomes, less in the trans-Golgi network and ~10% at plasma membrane. Irgm1 
localizes rather to places adjacent to or partially overlapping with CI-M6PR positive 
compartments (Figure 3.1, g-l). Furthermore, the distributed granular signal of Irgm1 
accurately colocalized with the late endosome/lysosome marker LAMP1 (Figure 3.2). By 
comparison, Irgm2 localizes exclusively to Golgi apparatus, with no extra signal overlapping 
with LAMP1 (Figure3.2, c). To confirm the apparent lysosomal localization of Irgm1, the 
acidotropic dye LysoTracker was loaded and cells were costained with anti-Irgm1 antibody 
1B2. Irgm1 was found to accumulate around the LysoTracker enriched compartments 
(Figure3.2, e-g). Hence, Irgm1 is associated with late endocytic/lysosomal compartments in 
addition to Golgi apparatus.  
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Figure 3.1 Irgm1 localizes to Golgi apparatus. 
MEFs were treated with 200U/ml IFN-γ for 24 hours, fixed with 3% PFA in PBS, and stained for Irgm1 by goat antiserum 
P20 (a-c, g-l) or mouse monoclonal antibody 1B2 (d-f) and indicated marker proteins by indirect immunofluorescence. Irgm1 
accurately colocalized with GM130 (a-c) and TGN38 (d-e), and localized to adjacent places or partially colocalized with the 
CI-M6PR positive compartments (j-l are the enlargement of the squares in g-i, respectively). Magnification: a-c 400x, d-l 
630x. Nuclei were labelled with DAPI. 
To examine whether Irgm1 also localizes to the early and recycling endocytic compartments, 
IFN-γ induced MEFs were labeled either with Alexa-Fluor-546-labelled transferrin for 5 
minutes or pulsed with transferrin for 10 minutes, then chased for 30 minutes, to label early or 
recycling endosomes, respectively. Transferrin is a serum glycoprotein that binds Fe3+ ions 
for delivery to the cells through receptor-mediated endocytosis into early endosomes. In acid 
environment (endosomes) the Fe3+ is released from transferrin-receptor complex and the 
transferrin is recycled to the plasma membrane through the recycling endosomes 
(Rothenberger 1987). Fluorescent transferrin conjugates can therefore be used to label early 
and/or recycling endosomes. The diffuse granular signal of Irgm1 showed no manifest 
overlapping with early or recycling endosomes (Figure 3.3). Therefore, Irgm1 is not 
distributed in early/recycling endocytic compartments at a detectable level. 
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Figure 3.2 Irgm1 localizes to late endocytic/lysosomal compartments in addition to Golgi apparatus.  
a-d, MEFs were treated with 200U/ml IFN-γ for 24 hours, fixed with 3% PFA in PBS, and stained by indirect 
immunofluorescence using 1B2, 1D4B, and H53 against Irgm1, LAMP1 and Irgm2, respectively. Secondary Alexa Fluor 555 
labelled donkey anti-mouse, Alexa Fluor 488 labelled donkey anti-rat, and Alexa Fluor 647 labelled donkey anti-rabbit 
antiserum were used, respectively. e-g, after treatment with 200U/ml IFN-γ for 24 hours, cells were incubated with 50 nM 
LysoTracker Red DND-99 for 30 minutes in the full medium, fixed with 3% PFA in PBS, and stained for Irgm1 by 1B2 
antibody. Irgm1 was found to associate with LAMP1 positive compartments (a-d) and accumulate around the LysoTracker 
enriched compartments (e-g) in addition to Golgi localization. Irgm2 localizes exclusively to Golgi apparatus (c). 
Magnification: 630x. Nuclei were labelled with DAPI. 
 
To conclude, Irgm1 localizes to Golgi apparatus, including cis-Golgi and trans-Golgi 
networks. In addition, Irgm1 also localizes to the late endocytic/lysosomal compartments, but 
scarcely, if at all, to the early/recycling endocytic compartments.  
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Figure 3.3 Irgm1 is not associated with early or recycling endosomes.  
After treatment with 200U/ml IFN-γ for 24 hours, MEFs were incubated with Alexa-Fluor-546-labelled transferrin for 5 
minutes (a-c) or pulsed with transferrin for 10 minutes, then chased for 30 minutes (d-f). Cells were then fixed with 3% PFA 
in PBS and P20 goat antiserum was used to stain Irgm1 by indirect immunofluorescence. The granular signals from Irgm1 
were not found to associate with transferrin positive compartments. Magnification: 630x.  
3.2 Both N and C terminal EGFP-tag lead to the mislocalization of Irgm1 
Deretic et al reported that Irgm1 (LRG-47) is required to initiate an interferon-induced 
autophagic process as a protection mechanism against Mycobacterium tuberculosis infection 
(Gutierrez 2004; Singh 2006). This claim was based on over-expression experiments using C-
terminally EGFP-tagged Irgm1. However, Martens reported earlier that both N and C 
terminally tagged Irgm1 misbehave in cells (Martens 2004b). To investigate in depth which 
compartments tagged Irgm1 localize in cells, both N and C terminally EGFP-tagged Irgm1 
were expressed in MEFs and co-stained with Golgi marker protein GM130 and TGN38 by 
indirect immunofluorescence. EGFP-Irgm1 and Irgm1-EGFP both showed diffuse vesicular 
and dotty expression pattern throughout the cytoplasm. Colocalization with Golgi protein 
GM130 and TGN38 was abolished (Figure 3.4 and Figure 3.5). Many of those vesicular and 
dotty signals strongly colocalized with transferrin labeled early endosomes and recycling 
endosomes (Figure 3.6). As mentioned earlier, no colocalization was found between native 
IFN-γ induced Irgm1 and early and recycling endosomes (Figure 3.3). Furthermore, Irgm1-
EGFP construct showed strong colocalization with lysosomal marker LAMP1 while in EGFP-
Irgm1 version, lysosomal association was largely abolished (Figure 3.7). Since Irgm1 
associates with membrane independent of IFN-γ induced factors, we asked whether IFN-γ 
could influence the mislocalization of EGFP-Irgm1 and Irgm1-EGFP. Two constructs 
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Figure 3.4 N-terminally EGFP-tagged Irgm1 is dislodged from Golgi apparatus.  
EGFP-Irgm1 was transiently transfected into MEFs by using Fugene 6 transfection reagent. 24 hours later, cells were fixed 
with 3% PFA in PBS, stained for GM130 (a-c) and TGN38 (d-f) by indirect immunofluorescence. EGFP-Irgm1 was found to 
be absent from Golgi apparatus. Magnification: 630x. Nuclei were labelled with DAPI. 
 
 
Figure 3.5 C-terminally EGFP-tagged Irgm1 is not localized to Golgi apparatus.  
Irgm1-EGFP (pF25) was transiently transfected into MEFs by using Fugene 6 transfection reagent. 24 hours later, cells were 
fixed with 3% PFA in PBS, stained for GM130 (a-c) and TGN38 (d-f) by indirect immunofluorescence. Irgm1-EGFP was not 
colocalized with GM130 or TGN38. Magnification: 630x. Nuclei were labelled with DAPI. 
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Figure 3.6 N or C terminally EGFP-tagged Irgm1 mislocalize to early and recycling endosomes. 
EGFP-Irgm1 (a-f) and Irgm1-EGFP (pF25, g-l) was transiently transfected into MEFs by using Fugene 6 transfection reagent. 
24 hours later, cells were incubated with Alexa-Fluor-546-labelled transferrin for 5 minutes (a-c, g-i) or pulsed with 
transferrin for 10 minutes, then chased for 30 minutes (d-f, j-l). Cells were then fixed with 3% PFA in PBS and directly 
observed under microscope. The vesicular and dotty signals from EGFP-Irgm1 and Irgm1-EGFP strongly overlap with 
transferrin-labelled early and recycling endosomes. Magnification: 630x. 
 
 
 
were transfected into MEFs simultaneously induced with IFN-γ. The same manner of 
mislocalization of EGFP-Irgm1 and Irgm1-EGFP was observed (data not shown).  
In conclusion, N or C terminally EGFP-tagged Irgm1 does not localize to Golgi apparatus, 
and mislocalizes to early and recycling endocytic compartment. And this mislocalization is 
IFN-γ independent.  
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Figure 3.7 Irgm1-EGFP strongly associates with lysosomes, while EGFP-Irgm1 is largely absent from lysosomal 
compartments.  
EGFP-Irgm1 (a-c) and Irgm1-EGFP (d-f, pF25) was transiently transfected into MEFs by using Fugene 6 transfection reagent. 
24 hours later, cells were fixed with 3% PFA in PBS, stained for LAMP1 by indirect immunofluorescence. Irgm1-EGFP is 
strongly colocalized with LAMP1 while lysosomal association of EGFP-Irgm1 was largely abolished. Magnification: 630x. 
Nuclei were labelled with DAPI. 
 
 
 
3.3 Mislocalization of Irgm1 by EGFP tagging is nucleotide dependent. 
Irgm1 is associated with Golgi apparatus independent of nucleotide binding (Martens 2004b). 
To test whether mislocalization of Irgm1 caused by EGFP tagging is influenced by nucleotide 
binding, Irgm1 nucleotide binding deficient mutant (S90N) tagged with EGFP at N or C 
terminus were expressed in the cells. Notably more cytoplasmic reticular and vesicular signals 
were seen. However, Golgi localization of native Irgm1 was restored as shown by costaining 
with Golgi protein TGN38 (Figure 3.8) and GM130 (data not shown). The expression patterns 
of EGFP-Irgm1 (S90N) and Irgm1-EGFP (S90N) were similar to the localization of untagged 
nucleotide-binding deficient Irgm1 (S90N) (compare Figure 3.8 a, d with Figure 3.9 e, as well 
as Martens 2004b).  
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Figure 3.8 EGFP-Irgm1 S90N and Irgm1-EGFP S90N localize to Golgi apparatus. 
EGFP-Irgm1 S90N (a-c) and Irgm1-EGFP S90N (d-f) was transiently transfected into MEFs by using Fugene 6 transfection 
reagent. 24 hours later, cells were fixed with 3% PFA in PBS, stained for TGN38 by indirect immunofluorescence. Both 
constructs colocalize with Golgi marker TGN38, although significant proportion of transfected proteins display additional 
cytoplasmic reticular and vesicular signals. Magnification: 630x. Nuclei were labelled with DAPI. 
3.4 Phagosomal accumulation of Irgm1 is nucleotide dependent, but IFN-γ independent. 
In L929 and Raw264.7 cells, IFN-γ induced Irgm1 is rapidly recruited to active plasma 
membrane upon phagocytosis and remains associated with phagosomes as they mature. It was 
also reported that Irgm1 associates with Golgi apparatus in an IFN-γ and nucleotide 
independent manner (Martens 2004b). It was therefore attempted to analyze whether Irgm1 
can accumulate on the phagosomes independent of IFN-γ and if so, whether the association 
with phagosomes is regulated by the nucleotide binding motif. Due to expression of undefined 
phagocytic receptors in primary murine embryonic fibroblasts, 2-µm latex beads are 
extensively taken up after 4 hours of incubation (data not shown). Therefore, this 
phenomenon was used to study the accumulation of IRG proteins on the phagosomes. Irgm1 
wild type and nucleotide binding deficient mutant S90N were expressed in MEFs in the 
absence of IFN-γ and phagocytosis was initiated by incubating with 2-µm latex beads 
overnight. Indirect immunofluorescence was performed and LAMP1 staining was used as a 
marker for latex beads-containing phagosomes. Wild type Irgm1 strongly associated with 
latex beads-containing phagosomes while Irgm1 S90N lost the phagosomal accumulation 
(Figure 3.9). Transfected Irgm1 also colocalized with LAMP1 positive compartments in 
unstimulated phagocytic cells (Figure 3.9, arrows), as well as in cells not involved in 
phagocytosis (Figure 3.13). Irgm1 S90N still showed Golgi localization while lysosomal  
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Figure 3.9 Accumulation of Irgm1 on phagosomes is nucleotide dependent. 
Irgm1 wild type (a-d) and S90N mutant (e-h) in pGW1H vector were transiently transfected into MEFs for 24 hours by using 
Fugene 6 transfection reagent. During transfection, cells were incubated with 2-µm latex beads overnight. Cells were then 
fixed with 3% PFA in PBS and staining for Irgm1 and LAMP1. Irgm1 accumulates around the latex beads phagosomes while 
the destroying of the nucleotide binding site completely abolished the phagosomal accumulation. Arrows indicate the 
colocalization of transfected wild type Irgm1 with LAMP1 positive compartments. Magnification: 630x. Nuclei were labelled 
with DAPI. 
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Figure 3.10 Irgm1-EGFP accumulates on phagosomes while EGFP-Irgm1 does not. 
EGFP-Irgm1 (a-d) and Irgm1-EGFP (e-f) were transiently transfected into MEFs for 24 hours using Fugene 6 transfection 
reagent. During transfection, cells were incubated with 2-µm latex beads overnight. Cells were then fixed with 3% PFA in 
PBS and staining for LAMP1. Irgm1-EGFP accumulated around the latex beads phagosomes while EGFP-Irgm1 did not. 
Magnification: 630x. Nuclei were labelled with DAPI. 
 
distribution was largely abolished (Figure 3.9). To conclude, accumulation of Irgm1 on 
phagosomes is nucleotide dependent, but IFN-γ independent.  
As showed in Figure 3.7, Irgm1-EGFP showed strong lysosomal association, while EGFP-
Irgm1 did not. Consistent with this observation, Irgm1-EGFP showed strong accumulation on 
latex beads-containing phagosomes whereas EGFP-Irgm1 was absent from phagosomes 
(Figure 3.10). Like untagged Irgm1, the accumulation of Irgm1-EGFP on phagosomes is also  
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Figure 3.11 Irgm1-EGFP association with phagosomes is nucleotide dependent. 
EGFP-Irgm1 S90N (a-d) and Irgm1-EGFP S90N (e-f) were transiently transfected into MEFs for 24 hours by using Fugene 6 
transfection reagent. During transfection, cells were incubated with 2-µm latex beads overnight. Cells were then fixed with 
3% PFA in PBS and staining for LAMP1. Both constructs were absent from latex beads phagosomes. Magnification: 630x. 
Nuclei were labelled with DAPI. 
regulated by nucleotide binding. EGFP-Irgm1 S90N not longer associates with latex beads-
containing phagosomes (Figure 3.11). The different association of EGFP tagged Irgm1 wild 
type and nucleotide binding deficient mutant (S90N) to the latex beads-containing 
phagosomes were not changed when cells were treated simultaneously with IFN-γ (data not 
shown). 
In conclusion, the recruitment of Irgm1 to phagosomes is regulated by nucleotide binding and 
independent of IFN-γ induced factors. Phagosomal accumulation of Irgm1 is abolished by N-
terminal, but not by C-terminal EGFP-tag.   
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3.5 Amphipathic helix near the C-terminus is responsible for both Golgi and lysosomal 
targeting of Irgm1. 
It was previously reported that a predicted amphipathic helix near the C terminus (named αK 
helix after the analogy to Irga6 structure) is responsible for the proper Golgi localization of 
Irgm1. As a C-terminal tag, the αK helix is sufficient to target EGFP to the Golgi apparatus as 
defined by GM130. Disruption of amphipathicity by glutamate insertion into helical region 
abolished the Golgi localization in both EGFP-Irgm1 αK construct and Irgm1 full length 
protein (Martens 2004b). Since endogenous Irgm1 also exhibits lysosomal localization 
besides Golgi association in murine embryonic fibroblasts (Figure 3.2), the localization of 
EGFP Irgm1 αK construct was examined in MEFs. 46% of the cells transfected with EGFP-
αK construct indeed localized to the Golgi apparatus as showed by costaining of GM130 
(Figure 3.12, a-f and m-o). However, in other transfected cells (54%), EGFP-Irgm1 αK 
showed punctate structures throughout the cytoplasm. Many of those structures displayed 
accurate colocalization with lysosomal protein LAMP1 (Figure 3.12, j-i). In 14% of 
transfected cells, EGFP-Irgm1 αK expressing showed both Golgi and lysosomal localization 
(Figure 3.12, b-f and m-o). This is consistent with the observation that endogenous, IFN-γ-
induced Irgm1 has Golgi as well as lysosomal distribution. It has to be pointed out that some 
punctate structures showed neither co-localization with LAMP1-positive compartments nor 
early/recycling endosomes (data not shown), of which the cellular localization remained 
undefined.  
To test whether the αK helix is not only enough, but also necessary, for both Golgi and 
lysosomal localization, full length Irgm1 and ins 362,367E mutant, in which the 
amphipathicity of the αK targeting helix was destroyed by two glutamate insertions (Martens 
2004b), were transiently expressed in the cells without IFN-γ treatment. Wild type Irgm1 
showed both Golgi and lysosomal association like the endogenous IFN-γ induced protein 
(Figure 3.13). Irgm1 ins 362, 367E mutant was distributed as dotty structures throughout the 
cytoplasm that showed neither Golgi nor lysosomal localization (Figure 3.13 and (Martens 
2004b)). Thus the native amphipathic K helix is required for both Golgi and lysosomal 
targeting of full length Irgm1 protein. 
 44
                            Results-I  
 
Figure 3.12 EGFP-Irgm1 αK showed both Golgi and lysosomal localization. 
EGFP-Irgm1 αK construct was transiently transfected into MEFs for 24 hours by using Fugene 6 transfection reagent. Cells 
were then fixed with 3% PFA in PBS and staining for GM130 (a-i) and LAMP1 (j-o). 32% transfected cells (a-c) showed 
only Golgi localization and 54% (g-l) showed only dotty structures among which strong lysosomal localization was observed. 
Expression in 14% (d-f and m-o) transfected cells showed both Golgi and lysosomal localization. Magnification: 630x. 
Nuclei were labelled with DAPI. 
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Figure 3.13 Amphipathic K helix is responsible for lysosomal targeting of full length Irgm1 protein. 
Irgm1 wild type (a-c) and ins 362, 367E mutant (d-f) in pGW1H vectors were transiently transfected into MEFs for 24 hours 
by using Fugene 6 transfection reagent. Cells were then fixed with 3% PFA in PBS and staining for Irgm1 and LAMP1. Wild 
type Irgm1 is strongly associated with LAMP1 positive compartment, while Irgm1 ins 362, 367E mutant showed granular 
signals throughout cytoplasm which are overlapping with LAMP1 signals. Magnification: 630x. Nuclei were labelled with 
DAPI. 
 
 
Figure 3.14 EGFP-Irgm1 αK is not recruited to phagosomes.  
EGFP-Irgm1 αK was transiently transfected into MEFs for 24 hours by using Fugene 6 transfection reagent. During 
transfection, cells were incubated with 2-µm latex beads overnight. Cells were then fixed with 3% PFA in PBS and staining 
for LAMP1. Golgi only state (a-d), lysosomal state (e-h) and Golgi plus lysosomal state (i-l) of EGFP-Irgm1 αK are 
exclusively found to be absent from latex beads phagosomes, even though colocalization with LAMP1 outside of 
phagosomes was seen (arrows). Magnification: 630x. Nuclei were labelled with DAPI. 
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EGFP-Irgm1 αK showed Golgi and lysosomal localization that mimicked the full length 
protein. The next question was whether the αK helix is also responsible for phagosomal 
accumulation of Irgm1. EGFP-Irgm1 αK was expressed and cells were induced to 
phagocytose 2-µm latex beads. Interestingly, even though colocalization was seen between 
EGFP-Irgm1 αK and LAMP1 in phagocytic cells (Figure 3.14, arrows), latex beads 
phagosomes remained blank for EGFP-Irgm1 αK (Figure 3.14). This result indicates Irgm1 
αK helix alone is not sufficient for the phagosomal accumulation of full-length protein. 
To investigate the possible mechanisms of subcellular localization of Irgm1, an alanine 
mutagenesis scan was performed based on the targeting construct EGFP-Irgm1 αK. Single 
mutations of hydrophobic residues (C356A；I358A；V359A；F362A；F363A；L365A；
L366A) and hydrophilic residues (N360A；R364A；R367A) had no influence on EGFP-
Irgm1 αK localization (Golgi and/or Lysosome, Figure 3.16, only single hydrophilic mutant 
showed). Furthermore, double mutants of hydrophobic residues (F362A F363A and L365A 
L366A, not shown) and surprisingly, even the quadruple mutant (F362A F363A L365A 
L366A, Figure 3.15) did not change the Golgi/lysosomal localization of the EGFP-αK 
construct. However, if more than one charged residues were mutated to alanine (N360A, 
R364A；R364A, R367A；N360A, R364A, R367A；Figure 3.17), both Golgi and lysosomal 
 
 
Figure 3.15 Quadruple mutant EGFP-Irgm1 αK F362A F363A L365A L366A still localizes to Golgi and/or lysosomes. 
EGFP-Irgm1 αK quadruple mutant F362A F363A L365A L366A was transiently transfected into MEFs for 24 hours by 
using Fugene 6 transfection reagent. Then cells were fixed with 3% PFA in PBS and staining for GM130 (a-c) or LAMP1 (d-
f). Four hydrophobic residues mutation still showed localization at Golgi and/or lysosomes as wild type EGFP-Irgm1αK. 
Magnification: 630x. Nuclei were labelled with DAPI. 
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Figure 3.16 Mutations of single hydrophilic residue do not change the Golgi/lysosomal localization of EGFP-Irgm1 αK. 
EGFP-Irgm1 αK N360A (a-f), EGFP-Irgm1 αK R364A (g-l) and EGFP-Irgm1 αK R367A (m-r) were transiently transfected 
into MEFs for 24 hours by using Fugene 6 transfection reagent. Then cells were fixed with 3% PFA in PBS and staining for 
GM130 or LAMP1. The Golgi and/or lysosomal localization were not influenced by these mutations. Magnification: 630x. 
Nuclei were labelled with DAPI. 
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Figure 3.17 Golgi and lysosomal localization are simultaneously abolished when more than two hydrophilic residues 
are mutated in amphipathic helix of EGFP-Irgm1 αK. 
EGFP-Irgm1 αK N360A R364A (a-f), EGFP-Irgm1 αK R364A R367A(g-l) and EGFP-Irgm1 αK N360A R364A R367A (m-
r) were transiently transfected into MEFs for 24 hours by using Fugene 6 transfection reagent. Cells were then fixed with 3% 
PFA in PBS and staining for GM130 or LAMP1. The Golgi and lysosomal localization were completely abolished. The 
signals rather showed unspecific reticular structures throughout the cytoplasms. Magnification: 630x. Nuclei were labelled 
with DAPI. 
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localization were completely abolished simultaneously. Those mutants were rather distributed 
in an unspecific reticular structure throughout the cytoplasm. These results suggest that both 
the overall amphipathicity of the αK helix and the identity of the non-hydrophobic residues 
contribute together to the membrane and Golgi/lysosome localization of the αK helix.  
To summarize, the predicted amphipathic αK helix near the C-terminus is responsible for 
Golgi and lysosomal localization of Irgm1, and is in turn dependent on the amphipathic 
property of the helical region. It is possible that the specificity to Golgi and lysosomal 
membranes is determined by the identity of the polar residues. 
3.6 Artificial αK amphipathic peptide mimics the localization of endogenous Irgm1.  
Biochemical studies showed that Irgm1 behaves like an integral membrane protein, even 
though no transmembrane domain has been identified within the protein sequence. It was 
demonstrated that Irgm1 exclusively associates with membrane fraction of the cells (Martens 
2004b). In addition, attempts to purify recombinant Irgm1 protein failed due to insolubility. 
To investigate the possible mechanisms of Irgm1 localization, peptide corresponding to the 
targeting amphipathic sequences (SKLRLMTCAIVNAFFRLLRFLPCVCC) of Irgm1 was 
synthesized. The lysine in position 2 was covalently conjugated with biotin. Therefore the 
peptide could be loaded onto the tetrameric streptavidin protein, which has four biotin binding 
sites, to form a peptide-streptavidin tetrameric complex. This complex was further used as the 
antibody in standard immunofluorescence staining to test whether this artificial complex can 
mimic the localization of endogenous Irgm1 as well as EGFP-Irgm1-αK construct. 
Fluorochrome-labelled streptavidin was used as read-out. The detailed procedure to make 
peptide-streptavidin complex and fluoro-cytochemistry staining using this tetramer system are 
described in materials and methods. Figure 3.18 shows the staining pattern of Cy3 labelled 
streptavidin-Irgm1 αK tetrameric complex. Cy3-labeled streptavidin alone was used as 
control and pictures were taken with the same exposure time. The streptavidin-Irgm1 αK 
complex staining shows both perinuclear and vesicular structures which was similar to the 
localization of endogenous Irgm1 protein and the EGFP-Irgm1 αK targeting construct. Figure 
3.18 shows the costaining of Streptavidin-Irgm1 αK with endogenous Irgm1 together with 
Golgi marker GM130 and lysosomal protein LAMP1. Essentially, Streptavidin-Irgm1 αK 
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showed accurate localization with full length Irgm1 at both Golgi apparatus and lysosomes, 
although higher background was seen probably due to the intrinsic hydrophobic property of 
the peptide. To conclude, the streptavidin-peptide complex mimics the localization of 
endogenous Irgm1 and provides a valuable novel method to investigate the function of 
targeting motifs of proteins, especially those with unknown biochemical properties.  
 
 
Figure 3.18 Artificial αK amphipathic peptide mimics the localization of endogenous Irgm1. 
MEFs were treated with 200U/ml IFN-γ for 24 hours, fixed with 3% PFA in PBS. 8µM Irgm1-αK peptide (final 
concentration, b-h) was loaded on 20 µg/ml (0.33µM final) C3-streptavidin in PBS and spun down at 45,000 rpm for 30 
minutes. Then antibodies against indicated proteins were added into streptavidin-peptide solution and it was used as primary 
antibodies in immunofluorescence staining. 20 µg/ml Streptavidin (0.33µM final) alone (a) was used as control. Image a and 
b were taken by same exposure time. Colocalization was seen between streptavidin-Irgm1 αK peptide and endogenous Irgm1 
at both Golgi apparatus and lysosomes. Magnification: 630x. 
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3.7 Irgm1 is not recuited to Toxoplasma gondii ME49 strain vacuoles and is not 
absolutely necessary for IFN-γ-dependent cell-autonomous resistance against T. gondii 
ME49 strain. 
IRG proteins accumulate onto T. gondii parasitophorous vacuoles membrane and contribute to 
the vacuolar vesiculation and disruption, which lead to the elimination of parasites itself. At 
least five members of IRG family, namely Irga6, Irgb6, Irgd, Irgm2, and Irgm3 were found to 
accumulate onto the T. gondii PVM in primary astrocytes (Martens 2005). Irgm1 was not 
detected on the PVM (Butcher 2005; Martens 2005). However this observation was 
technically less satisfactory because the A19 antiserum had a significant cross-reaction with T. 
gondii itself. Therefore another goat anti-Irgm1 antiserum, P20, and monoclonal anti-Irgm1 
antibody 1B2 were used in the present studies to further confirm the absence of Irgm1 from T. 
gondii PVM. Figure 3.19 shows one image of P20 staining, in which Irgm1 is not present on 
GRA7 positive T. gondii vacuole. The same results were also obtained with the monoclonal 
antibody IB2 (Stefii, personal communication). As Irgm1 also localizes to lysosomal 
compartments, lysosomal fusion with T. gondii PVM was examined. Neither LAMP1 nor 
Irgm1 was present on T. gondii vacuole at 2, 4 and 6 hours after infection (Figure 3.19). This 
is consistent with the observation in primary astrocytes (Martens 2005).  
To test whether Irgm1 is necessary for IFN-γ-dependent cell autonomous resistance against T. 
gondii infection, the T. gondii proliferation assay was performed in Irgm1-deficient primary 
MEFs (performed by Stephanie Könen-Waisman). Surprisingly, even though Irgm1 is 
indispensable in vivo for mice to survive T. gondii infection, Irgm1 is not absolutely necessary 
in vitro at cellular level for the resistance against T. gondii (Figure 3.20). To examine whether 
other members of IRG proteins still accumulate on T. gondii vacuoles in the absence of Irgm1, 
Irgm1 MEFs deficient in Irgm1 were treated with 200U/ml IFN-γ for 24 hours, infected with 
T. gondii ME49 strain and indirect immunofluorescence were performed. Figure 3.21 shows 
that in Irgm1 deficient MEFs, Irga6, Irgb6 and Irgm2 still accumulate on T. gondii vacuole 
membrane and the same disrupted morphology of PVM is observed as in the wild type MEFs. 
However, punctate Irga6 and Irgb6 signals were noticed that is absent in wild-type MEFs 
(arrows). To get a quantitatively information, wild type and Irgm1 deficient MEFs were 
treated with IFN-γ for 24 hours, infected with T. gondii ME49 strain and stained for  
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Figure 3.19 Irgm1 is not recuited to T. gondii parasitophorous vacuole membrane.  
MEFs were treated with 200U/ml IFN-γ for 24 hours and then infected with ME49 for 2 (a-d) or 4 (e-h) hours. Cells were 
fixed with 3% PFA in PBS and stained for indicated proteins. Irgm1 was found not to associate with T. gondii vacuolar 
membrane (a-d), and no lysosomal fusion was seen for T. gondii vacuoles (e-h). Arrows indicate the intracellular parasites. 
Magnification: 630x.  
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Figure 3.20 Irgm1 is not absolutely necessary for IFN-γ-dependent cell-autonomous resistance against T. gondii ME49 
strain in MEFs. (performed by Stephanie Könen-Waisman) 
MEFs isolated from wild-type (a) or Irgm1 knout-out (b) mice were induced with the indicated concentrations of IFN-γ for 
24 hours and infected with T. gondii ME49 strain by different multiplicities of infection. 48 hours later, 1µCi/well [3H]-uracil 
were added to the culture and incubated for additional 24 hours. The amount of incorporated uracil, which is directly in 
proportion to T. gondii growth, was determined by liquid scintillation counting. The IFN-γ-treated Irgm1-deficient MEFs can 
control ME49 growth to a similar level in the wild-type cells. 
 
Figure 3.21 Other IRG proteins still accumulate onto T. gondii ME49 strain vacuoles in Irgm1 deficient MEFs. 
Irgm1 deficient MEFs were treated with 200U/ml IFN-γ for 24 hours and then infected with ME49 for 2 hours. Cells were 
fixed with 3% PFA in PBS and stained for indicated proteins. Even in the absence of Irgm1, at least three members of IRG 
family, namely Irgm2 (detected by rabbit antiserum H53, a-d), Irga6 (rabbit antiserum 165, f) and Irgb6 (goat antiserum A20, 
e) are still accumulated on T. gondii vacuolar membranes (arrow heads indicate the intracellular T. gondii). Aggregated Irga6 
and Irgb6 were noticed (arrows). Magnification: 630x. Nuclei were labelled with DAPI. 
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Irga6 and Irgb6. Images were taken with same exposure time and signal intensities were 
measured for Irga6 and Irgb6 on T. gondii vacuoles. Figure 3.22 shows that in Irgm1 deficient 
MEFs, the loading of Irga6 and Irgb6 onto the PVM is decreased by about 30% compared to 
those in wild type cells. However, this decrease in loading of other members of IRGs on PVM 
seems not to have a significant influence on the cell-autonomous control of T. gondii growth, 
since Irgm1 deficient MEFs control intracellular T. gondii ME49 strain essentially as 
efficiently as the wile type cells.  
We therefore conclude that Irgm1 is not absolutely required for IFN-γ-dependent cell-
autonomous resistance against T. gondii ME49 strain in murine fibroblasts. 
 
 
 
Figure 3.22 The accumulation of Irga6 and Irgb6 on PVM is decreased in Irgm1 deficient MEFs. 
Wild type and Irgm1 deficient MEFs were treated with 200U/ml IFN-γ for 24 hours and then infected with T. gondii ME49 
strain for 2 hours. Cells were fixed with 3% PFA in PBS and stained for Gra7 to identify intracellular parasites, as well as 
165 for Irga6 and A20 forIrgb6. Gra7 positive vacuoles were randomly selected and images were taken at same exposure 
time for either Irga6 or Irgb6. Signals intensities of Irga6 (a) and Irgb6 (b) on PVM were measured by pixel counting and 
plotted as showed. Mean values are depicted by violet bars. Both Irga6 and Irgb6 signals on PVM were decreased by about 
30%. 
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4. Results-II 
4.1 Dynamics of the Irga6-loading onto the T. gondii ME49 strain parasitophorous 
vacuolar membrane 
At least 5 members of the IRG family have been reported to accumulate onto the T. gondii 
parasitophorous vacuolar membrane and contribute to the disruption of the vacuole, resulting 
in the death of the parasites by unknown mechanisms (Martens 2005). To investigate the 
mechanisms of IFN-γ-dependent cell autonomous resistance against T. gondii infection and 
the role of IRG proteins in this process, a live cell imaging system was established. This 
method allowed us to document the accumulation of IRG proteins onto T. gondii vacuoles and 
the disruption of vacuoles by time-lapse microscopy. EGFP-ctag1-Irga6 fusion protein has the 
same ER-localization as endogenous Irga6 and is recruited to T. gondii PVM as well, and was 
therefore used in the present live cell imaging experiments. Mouse embryonic fibroblasts 
were transfected with EGFP-tagged-Irga6 construct and simultaneously treated with 200U/ml 
IFN-γ. Twenty four hours later, cells were infected with T. gondii avirulent ME49strain and 
observed in the live cell imaging system. Figure 4.1 shows two examples of Irga6 
accumulation onto the T. gondii vacuoles. In the first movie, signal of Irga6 on the PVM was 
detectable from 26 minutes after the infection, and signal increased rapidly to the maximum 
capacity of the camera within 15 minutes. The accumulation of Irga6 on the PVM was 
accompanied by a global reduction of cytoplasmic Irga6 signal. In the second movie, one 
parasite invaded a host cell that is already infected by an earlier parasite, which is already 
coated with Irga6. Signal of Irga6 started to accumulate on the second T. gondii PVM around 
6 minutes after the invasion of this parasite. For this individual it took 50 minutes for Irga6 to 
reach the plateau. Quantification of Irga6 signal intensities on PVM is shown in Figure 4.1 c. 
Interestingly, the directly observed lag phase between the entry of the parasites and the 
initiation of accumulation of Irga6 on PVM varied from less than 6 minutes to more than 12 
hours and some parasite vacuoles remained uncoated with Irga6 as long as the conditions of 
cell culture allowed (more than 12 hours, data not shown). 
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Figure 4.1 Accumulation of Irga6 on the T. gondii ME49 strain parasitophorous vacuole membrane.  
MEFs were transiently transfected with Irga6-ctag1-EGFP and treated with 200U/ml IFN-γ. 24 hours later cells were infected 
with ME49. Images were taken by time-lapse microscopy. (a) The time-lapse images were taken immediately after infection 
and one intracellular parasite (arrows) was already observed when the first frame started. (b) When the video was running, an 
extracellular T. gondii invaded the host cell, which already had one parasite infected and Irga6 accumulated on it. Timing was 
set as zero when this invading parasite was observed. Arrows showed the second invaded T. gondii. (c) Quantification of 
signal intensities of Irga6 on the vacuoles in (a) and (b). Magnification: 400x. 
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4.2 Disruption of the Irga6-positive T. gondii vacuoles is followed by parasite 
deterioration and host cell death 
Compared to the variable accumulation of Irga6 onto the T. gondii PVM, the disruption of 
parasitophorous vacuole is fast and uniform. Figure 4.2 shows two examples of T. gondii 
PVM disruption processes. Consecutive time-lapse images were taken with one minute 
intervals. In both cases, the disruption processes of Irga6-positive T. gondii vacuoles happen 
within 3 minutes. The initially intact Irga6-positive vacuolar membranes suddenly break on 
one end and the parasites are exposed to the cytosol.  
To observe the fate of the stripped parasites in the cytosol, longer intervals between 
consecutive time-lapse images (3-5 minutes) were further taken to minimize the toxic effect 
of the illuminating light beam. The T. gondii apparently deteriorate in the cytosol as the phase 
behavior of the parasite changes. The T. gondii tachyzoites initially with high phase density 
changed to a phase-transparent form after stripping of the PVM (Figure 4.3). This 
deterioration of T. gondii has been observed only after the disruption of Irga6-positive 
vacuoles.  
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Disruption of Irga6-positive T. gondii ME49 strain vacuoles 
MEFs were transiently transfected with Irga6-ctag1-EGFP and treated with 200U/ml IFN-γ. 24 hours later cells were infected 
with ME49. Images were taken by time-lapse microscopy. (a) and (b) show the disruption of the T. gondii vacuoles from two 
individual experiments (arrows). Magnification: 400x. 
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Figure 4.3 T. gondii deteriorates in the cytosol after the disruption of vacuoles. 
MEFs were transiently transfected with Irga6-ctag1-EGFP and treated with 200U/ml IFN-γ. 24 hours later cells were infected 
with ME49. 1hours after infection, images were taken by time-lapse microscopy. (a) shows the T. gondii in the beginning of 
the experiments. Disruption of the vacuole happened at 135 minutes p.i. After that the parasite underwent morphological 
changes. It was rounded up (b) and appeared to be in a transparent form (c) in the cytosol. Arrows indicate the T. gondii. 
Magnification: 400x. 
 
 
Surprisingly, but uniformly, dying of the infected host cells was further observed after the T. 
gondii vacuoles had been disrupted and the parasites deteriorated. The dying of the host cells 
was confirmed by propidium iodide staining and possible effect of deteriorating culture 
conditions was excluded, since the infected cell death was observed repeatedly and the 
uninfected neighboring cells were always alive. The dying host cells showed characteristics of 
shrinkage of nuclei, condensed cytoplasm, overall breakdown of cellular structures, and loss 
of mobility. Figure 4.4 shows consecutive frames from one infected cell in which Irga6 was 
already accumulated on the PVM when the movie started. Propidium iodide was present in 
the medium, but was initially excluded. Between 190 and 210 minutes p.i. the cell became 
permeate to PI indicating the loss of plasma membrane integrity. The T. gondii vacuole was 
disrupted at 170 minutes after infection and the host cell die between 20 and 40 minutes later. 
The Irga6 signals disappeared completely shortly after the cell became PI-permeable, 
suggesting that PVM-associated Irga6 was either completely disassembled from membrane 
and released from the dead cell, or else was proteolytically digested. 
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Figure 4.4 Host cell lose the plasma membrane integrity and die after the disruption of T. gondii vacuole. 
MEFs were transiently transfected with Irga6-ctag1-EGFP and treated with 200U/ml IFN-γ. 24 hours later cells were infected 
with ME49 for 90 minutes and images were taken by time-lapse microscopy. Propidium iodide (1µg/ml) was present in the 
medium. 210 minutes after infection, the nucleus of host cell became positive for PI and overall cellular structures collapsed. 
Arrow shows the disruption of Irga6 positive vacuole. Magnification: 400x. 
4.3 EGFP-LC3 associates with a proportion of T. gondii ME49 strain vacuoles 
independent of IFN-γ  
Recent publications reported that autophagy plays a role in elimination of intracellular T. 
gondii. A process of indentation, vesiculation, disruption and stripping of the parasite PVM 
has been observed in primed effector macrophages. Denuded parasites were apparently 
enveloped in autophagosome-like vacuoles, which ultimately fused with lysosomes (Ling 
2006). Similar PVM vesiculation and disruption processes have been reported in primary 
astrocytes as well. Although lysosomal fusion with T. gondii parasites were not observed in 
this study, EGFP-LC3, a marker for autophagosomes, was found to accumulate in the vicinity 
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of denuded parasites (Martens 2005). To investigate the role of autophagy in IFN-γ mediated 
resistance against T. gondii, EGFP-LC3 was again used in the present study by 
immunofluorescence staining in fixed samples, as well as in the established live cell imaging 
system. MEFs were transfected with EGFP-LC3 construct, induced with 200U/ml IFN-γ or 
left untreated. Twenty four hours later, cells were infected with ME49 T. gondii strain and 
EGFP-LC3 immunofluorescence was observed. Figure 4.5 shows that EGFP-LC3 can 
accumulate on some, but not all, T. gondii vacuoles. In (a) and (b), the cells were not treated 
with IFN-γ. Arrows indicate the EGFP-LC3 coated T. gondii vacuoles and arrow heads 
indicate the other EGFP-LC3-negative vacuole in the same cell. T. gondii vacuoles in this cell 
are obviously not disrupted. Cells in (c-d) are treated with IFN-γ and infected with T. gondii 
for 2 hours. Arrows indicate the disrupted, Irga6-coated T. gondii vacuole, and EGFP-LC3 is 
weakly associated with this disrupted vacuole. In e-h, cells were treated with IFN-γ and 
infected with T. gondii for 6 hours. Arrows in (e and f) indicate the EGFP-LC3 positive, but 
Irga6 negative vacuole and arrow heads indicate the Irga6-positive, but EGFP-LC3 negative 
vacuole. Notice that there are two more vacuoles in the same cell which are not coated with 
either Irga6 or EGFP-LC3. In (g and h), the arrows indicate the disrupted, Irga6-positive T. 
gondii vacuole. EGFP-LC3 is negative for this vacuole; despite that enhanced EGFP-LC3 
aggregates are obviously visible in this cell.    
In live cell imaging experiment, EGFP-LC3 has been found to be weakly associated with T. 
gondii PVM as well as denuded parasite itself (Figure 4.6, arrows). Again the host cell died 
eventually and no manifest high level of autophagy was observed. EGFP-LC3 was then 
released completely from dead host cells implying that the host cell plasma membrane was 
permeabilized. We noticed, however, that before the permeabilization of host cell plasma 
membrane, the intracellular parasite itself was penetrated by EGFP-LC3 (arrows). This 
seemed to imply that the T. gondii membrane itself became permeable to a soluble protein, 
confirming that the T. gondii was now dead. This effect had nothing special to do with the 
LC3 moiety of the EGFP-LC3 fusion protein since, in repeated experiments, it was observed 
that the parasites from stripped vacuoles became permeate to EGFP or other fluorescent 
proteins alone. These results show that the disruption and the stripping of the T. gondii 
vacuoles in IFN-γ-treated cells leads directly to the death of parasites in the cytosol. In  
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Figure 4.5 EGFP-LC3 associates with some T. gondii vacuoles in MEFs 
MEFs were transfected with EGFP-LC3 and treated with 200U/ml IFN-γ (c-h) or left untreated (a-b). 24 hours later cells 
were infected with ME49 for 2 hours (a-f) or 6 hours (g-h). (a-b) arrows indicate the EGFP-LC3 coated T. gondii vacuoles 
and arrow heads indicate the other EGFP-LC3-negative vacuole. (c-d) arrows indicate the disrupted, Irga6-coated and weakly 
EGFP-LC3 associated T. gondii vacuole. (e-f) arrows indicate the EGFP-LC3 positive, but Irga6 negative vacuole and arrow 
heads indicate the Irga6-positive, but EGFP-LC3 negative vacuole. Notably, there are two more vacuoles which are not 
coated with either Irga6 or EGFP-LC3. (g-h) arrows indicate the disrupted, Irga6-positive and EGFP-LC3 negative T. gondii 
vacuole and enhanced EGFP-LC3 aggregates are visible. Magnification: 630x. 
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Figure 4.6 EGFP-LC3 weakly associates with T. gondii vacuole as well as denuded parasite in IFN-γ treat MEFs 
MEFs were transiently transfected with EGFP-LC3 and treated with 200U/ml IFN-γ. 24 hours later cells were infected with 
ME49 for 120 minutes and images were taken by time elapse microscopy. Weak association was observed with T. gondii 
vacuole as well as denuded parasite (arrows). 180 minutes after infection, intracellular T. gondii was permeablized as EGFP-
LC3 diffused into the vacuole and parasite itself accompanied by phase contrast change of the Toxoplasma. Host cell died 
275 minutes after the infection and EGFP-LC3 signal was vanished from dead cell. No eminent autophagosome formation 
was seen in the process of parasite permeabilization and host cell death. Magnification: 400x. 
 
addition, the change in the phase properties of T. gondii has roughly the same timing as the 
entry of soluble proteins. Thus it seemed that entry of soluble fluorescent proteins (EGFP) 
into individual T. gondii could be used as a direct method to give a time point for the death of 
individual parasites in live cell experiments. 
4.4 Intracellular T. gondii is killed after the disruption of parasitophorous vacuole 
In order to examine the timing and possible relationship between the disruption of T. gondii 
vacuole and the permeabilization (killing) of the parasite itself, Irga6-ctag1-EGFP and a 
construct coding for the red fluorescent protein (pmDsRed C3) were co-transfected into MEFs 
and the whole succession of events was documented by live cell imaging. Figure 4.7 shows 
one movie in which the evolution of two Irga6 positive T. gondii vacuoles in one cell was 
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documented. One vacuole was disrupted at 70 minutes p.i. and the parasite became permeate 
to DsRed at 20 minutes later (90mins pi). The other vacuole was disrupted at 100 minutes p.i. 
and this parasite permeabilized at 145 minutes p.i.. Finally the host cell died at 150 minutes 
p.i.. It is worth noting that during the whole process, one intracellular parasite remained Irga6 
negative and mDsRed negative until the host cell died (arrows). Table 4.1 shows the timing of 
the experiments that were documented by live cell imaging. Although the time between the  
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Figure 4.7 Intracellular T. gondii are permeabilized after the disruption of parasitophorous vacuoles.  
MEFs were cotransfected with Irga6-ctag1-EGFP and pmDsRed C3 constructs, treated with 200U/ml IFN-γ for 24 hours and 
infected with T. gondii ME49 strain. 60 minutes after infection three intracellular parasites were observed and two of them 
were coated with Irga6. Images were then taken by time elapse microscopy and consecutive frames are shown. One vacuole 
was disrupted at 70 min p.i. and parasite was permeablized at 90 min p.i.. The other vacuole was then disrupted at 100 min 
p.i. and permeablized at 145 min p.i.. 5 minutes later the host cell died and the DsRed signal was vanished from the host cell, 
as showed in the last frame. The Irga6 uncoated T. gondii (arrows) remained Irga6 and DsRed negative until the host cell 
death. Magnification: 400x 
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Table 4.1 Timing of the T. gondii vacuolar disruption, subsequent permeablization of stripped parasites and the final 
host cell death in live cell imaging experiments. 
Nr. Starting of experiments   Disruption of PV Entry of EGFP/mDsRed Cell death 
1 120 135  415 
2 120 135  220 
3 150 160  180 
4 120 *  130 
5 60 96  120 
6 180 *  260 
7 90 170  195 
8 120  180 265 
9 60  80 110 
10 60  175/200(135pi#) 280 
11 0  145 225 
12 60 70 90 150 
  100 145 150 
13 0 44 62 88 
14 120 170 185 190 
15 240 255 283 328 
16 0 36 51 81 
17 140 140 155 260 
MEFs were treated with 200U/ml IFN-γ and transfected with EGFP-cTag1-Irga6 (1-7), pEGFP-C3 (8-11) or cotransfected 
with EGFP-cTag1-Irga6 and pmDsRed/pCherry (12-17) for 24 hours. Cells were then infected with T. gondii ME49 strain 
and observed by live cell imaging system from indicated time after infection. In Nr.4 and 6, * indicates that the T. gondii 
vacuole was already disrupted when the movie started. In Nr.10, # indicates that the second parasite invaded the host cell 
while the film was running and was permeablized at 135 minutes after its invasion. In Nr.12, there were two intracellular T. 
gondii coated with Irga6 and their timings are given respectively. All numbers have units as minutes after infection.  
 
infection and  host cell death ranged in different experiments from 81 to 415 minutes, the time 
intervals between the disruption of vacuoles and the permeabilization of parasite itself were 
much more constant, ranging from 15 to 45 minutes (15, 15, 18, 20, 27, 28, 45 minutes). 
4.5 Host cell death is a mechanism of IFN-γ-dependent cell-autonomous resistance 
against T. gondii avirulent strain. 
The host cell death after the disruption of the T. gondii vacuoles seemed to be inevitable 
despite the fact that the stripped parasite had been killed before host cell death. To document 
this phenomenon on the population level, MEFs were seeded at the same density, treated with 
IFN-γ or left untreated for 24 hours, and infected with T. gondii ME49 strain. 24 hours after 
infection, the cell monolayer was observed directly under inverted microscope (Figure 4.8). 
IFN-γ treatment alone or T. gondii infection alone did not have effects on host cell density. In 
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T. gondii infected IFN-γ untreated cells, the multiplication of parasites could be observed (not 
shown). However, in IFN-γ-treated, ME49 infected cells, the cell density was notably 
decreased. Furthermore, cell debris could be observed and no parasite could be found in 
remaining live cells. 
 
 
 
 
 
 
 
 
 
Figure 4.8 Cell density was decreased in the IFN-γ-induced and T. gondii ME49 strain infected host cells.  
MEFs (1x105) were seeded at the same density, treated with IFN-γ or left untreated for 24 hours, and infected with ME49 
with MOI of 10. 24 hours later, images were taken by inverted Zeiss Axiovert 200M microscope. Cell density was decreased 
in presence of both IFN-γ and ME49 infection and cell debris could be observed. There is no significant density difference 
between cells only treated with IFN-γ, or only infected with ME49, or with control conditions alone. Magnification: 200x. 
 
Quantification of host cell viability was performed based on a standard colorimetric assay. 
Avirulent T. gondii strain ME49 caused a significant decrease of host cell viability in an IFN-
γ dependent manner (Figure 4.9a). Virulent T. gondii strain RH-YFP had no similar death-
causing effect on either IFN-γ treated or untreated host cells (Figure 4.9b). This is consistent 
with the observation that IFN-γ-treated cells are unable to efficiently control the virulent T. 
gondii strain, like RH-YFP (Figure 4.10). Therefore it is in turn suggesting that the IFN-γ-
dependent host cell death could be an elimination mechanism against T. gondii, which is 
effective against avirulent strain, but rather ineffective against virulent strain.  
Interestingly, IFN-γ induced L929 fibroblasts failed to die in presence of ME49 infection 
(Figure 4.9 c,d). This is, however, consistent with the observation that, unlike other cell lines 
and primary cells, L929 cells cannot control T. gondii ME49 multiplication efficiently upon 
IFN-γ induction (Konen-Waisman 2007), further suggesting that the host cell death is indeed 
a mechanism for the elimination of intracellularT. gondii. 
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To conclude, host cell death seems to be a novel and important component in the mechanism 
of IFN-γ-dependent cell-autonomous resistance against T. gondii avirulent strain infection.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Effects of IFN-γ and T. gondii infection on host cell viability.  
MEFs (a, b) and L929 cells (c, d) were seeded into 96 well plates (5x103/well) and induced with indicated dose of IFN-γ for 
24 hours. Cells were then infected with T. gondii avirulent strain ME49 (a, c) or virulent strain RH-YFP (b, d) for 24 hours. 
Cell viability were measured and expressed as percentage of uninfected cells. ME49 infection cause significant decrease of 
cell viability in presence of IFN-γ in MEFs while RH-YFP has no effect. Viability of L929 cells was not affected by IFN-γ 
and/or T. gondii infection. 
 
 
 
 
 
 
 
Figure 4.10 IFN-γ mediated cell-autonomous control of T. gondii avirulent (ME49) and virulent (RH-YFP) strains. 
(performed by Stephanie Könen-Waisman) 
MEFs were treated with 100U/ml IFN-γ or left untreated for 24 hours and infected with T. gondii avirulent ME49 strain or 
virulent RH-YFP strain by different multiplicities of infection. 48 hours later, 1µCi/well [3H]-uracil were added to the culture 
and incubated for additional 24 hours. The T. gondii growth was determined by liquid scintillation counting. The growth of 
ME49 strain was completely inhibited in IFN-γ treated cells, and almost no viable parasite could be detected. However, the 
RH-YFP strain can still grow in IFN-γ treated cells, although to a less extent compared to the IFN-γ untreated cells.  
 69
 
                            Results-II  
4.6 The property of host cell death induced by IFN-γ and T. gondii avirulent strain 
infection is rather necrosis than apoptosis.  
It is well established that intracellular T. gondii could extensively modify host cell signalling 
pathways resulting in an anti-apoptotic state in the host cell that presumably favours the 
intracellular growth of the parasites (Carmen 2007). T. gondii infected cells are resistant to 
numerous apoptotic stimuli (Carmen 2006). As shown above, IFN-γ treated murine 
fibroblasts can apparently override the anti-apoptotic effect of T. gondii infection and initiate 
host cell death, but only on condition that the PVM can first be disrupted, which is supposed 
to be the responsibility of the IRG proteins. However, the nature of this IFN-γ-dependent host 
cell death was unknown, and was therefore investigated.  
Cytochrome C is a key molecule in apoptosis. It is released by the mitochondria in response 
to pro-apoptotic stimuli and facilitates the formation of the apoptosome, which further leads 
to the activation of caspases cascades, and finally apoptotic death of the cell (Goldstein 2000). 
Therefore, indirect immunofluorescence staining was performed to analyze whether 
cytochrome C is released during the process of ME49 infected IFN-γ treated host cell death. 
As positive control, cells were treated with TNF-α and cycloheximide to induce apoptosis. 
Figure 4.11 shows that in normal cells, cytochrome c is localized to mitochondria while 
during apoptosis it is released into cytosol and showed diffused staining pattern (Figure 4.11 
b). No cytochrome c release was detected during cell death caused by T. gondii infection at 
any time point (Figure 4.11 c, d). This result does not exclude the possibility that cytochrome 
c may be released right before the cell death. However, it suggests that the T. gondii infection 
induced cell death is non-apoptotic since during apoptosis the release of cytochrome c 
normally happens several hours before cell death (Goldstein 2000).  
In normal viable cells, phosphatidylserine (PS) is located on the cytoplasmic face of the cell 
membrane. However, in apoptotic cells, PS is translocated from the inner to the outer leaflet 
of the plasma membrane, and is exposed to the external environment. Annexin V, a Ca2+-
dependent PS binding protein, is used as an early marker for apoptosis (Koopman 1994). We 
investigated in live cell imaging system whether and when PS was externalized during T. 
gondii infection induced cell death by adding Alexa-555 labelled Annexin V to the medium. 
To identify the timing of the host cell death, EGFP was expressed in the cells and released  
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Figure 4.11 Cytochrome C is not released during the process of ME49-infected IFN-γ-treated host cell death.  
MEFs were treated with 200U/ml IFN-γ for 24 hours (c, d), and infected with ME49 for 3 hours. As control, MEFs were 
treated with 40ng/ml TNFα combined with 10 cycloheximide µg/ml for 4 hours. Construct coding for EGFP was transiently 
transfected into cells (c,d). Cells were fixed with 3% PFA in PBS and stained for Cytochrome C (red, a-d) and Gra7 (magenta, 
c-d). Arrow indicates one permeabilized parasite and EGFP protein is diffused into it. No Cytochrome C was found to be 
released from mitochondria in ME49 infected IFN-γ treated cells. Magnification: 630x. Nuclei were labelled with DAPI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Phosphatidylserine is not externalized before host cell death.  
MEFs were treated 200U/ml IFN-γ and transiently transfected with pEGFP-C3 construct. After 24 hours, cells were infected 
with ME49 for 60 minutes and images were taken by time elapse microscopy. Alexa Fluor 555 labelled annexin V (1:100) 
and 2.5mM CaCl2 were added to the medium. No annexin V signal was seen before the infected cell died and accumulated to 
overall cell membrane debris after the EGFP was released from the dead cell. Arrow shows the permeablization of one 
parasite. Magnification: 400x 
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into the medium when the cell plasma membrane was permeablized. As showed in Figure 
4.12, Annexin V signals remained negative at the cell plasma membrane for a long time and 
only started to accumulate on the overall cellular membrane debris after the EGFP signal 
disappeared from the cell. This result further confirmed that the IFN-γ treated host cell death 
by T. gondii infection is non-apoptotic. 
High-mobility group box 1 (HMGB1), normally functioning as an intranuclear architectural 
protein within the healthy cells, is emerging as an important proinflammatory mediator which 
is released from cells undergoing necrosis (Scaffidi 2002; Chen 2004). This prompted us to 
examine whether HMGB1 was released during T. gondii infected host cell death. TNF-α plus 
cycloheximide was used to induce apoptosis as control. During apoptosis, caspase-3 is a 
pivotal executor proteinase which undergoes activating cleavage. In turn, caspase-3 cleaves 
PARP and other downstream substrates. Caspase-3 and PARP cleavage were also examined 
by western blot analysis. Figure 4.13 showed that in the presence of IFN-γ, T. gondii avirulent 
ME49 strain infection induced HMGB1 release from host cells. Neither caspases-3 nor PARP 
was cleaved in this process, though both were cleaved during TNF-α-CHX induced apoptosis. 
In the absence of IFN-γ, T. gondii infection did not induce HMGB-1 release or caspases-3 
activation (Figure 4.13).  
In conclusion, a further mechanism of IFN-γ dependent cell autonomous resistance against 
Toxoplasma gondii appears to be induced host cell necrosis. 
 
 
 
 
 
 
 
Figure 4.13 HMGB1 is released, but caspase-3 is not activated, during IFN-γ-treated ME49-infected host cell death.  
MEFs treated with 200U/ml IFN-γ for 24 hours or untreated were infected with ME49 for indicated time. As control, cells 
were treated with 40ng/ml TNFα and 10 cycloheximide µg/ml to induce apoptosis. Cell culture supernatant (for HMGB1) or 
cell lysate (for caspases-3 and PARP) were collected at indicated time and subjected to western blot analysis. Calnexin was 
detected as loading control. HMGB1 was found to be released from ME49 infected IFN-γ treated cells, but not from cells 
infected with ME49 without IFN-γ treatment, also not from apoptotic cells. Neither caspase-3 nor PARP cleavage was found 
in T. gondii infected cell, whereas in apoptotic cells, both caspases-3 and PARP were cleaved 
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4.7 Cathepsin B is not necessary for the IFN-γ-dependent T. gondii avirulent strain 
elicited host cell necrosis. 
Cathepsins are a family of lysosomal proteases which function normally inside lysosomes and 
have vital roles in cellular protein turnover. Among these, cysteine protease Cathepsin B and 
aspartic protease Cathepsin D are the most abundant and have mostly often been linked to cell 
death (Broker 2005; Golstein 2007; Willingham 2007).  
To analyze the possible role of Cathepsin B in T. gondii induced host cell necrosis, Cathepsin 
B deficient embryonic fibroblasts were tested for their viability during T. gondii avirulent 
ME49 strain infection. As Figure 4.14 (a, b) shows, Cathepsin B deficient MEFs showed IFN-
γ dependent ME49 induced cell death, which were also seen in wild type cells. Western blots 
(Figure 4.14, c) showed that during cell death, HMGB-1 was released to the same extent in 
Cathepsin B deficient cells as in the wild type cells. Furthermore, Cathepsin B deficient MEFs 
can control ME49 strain growth upon IFN-γ treatment as efficiently as wild type cells (data 
not shown). Therefore, we conclude that Cathepsin B is dispensable in the IFN-γ-dependent T. 
gondii avirulent strain induced host cell necrosis.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Cathepsin B is not necessary for the IFN-γ-dependent T. gondii ME49 strain elicited host cell necrosis.  
Wild type (a) and Cathepsin B deficient (b) MEFs were seeded into 96 well plates (7.5x103/well) in the presence of 200U/ml 
IFN-γ or without IFN-γ for 24 hours and infected with ME49 for 8 hours. Cell viability were measured and expressed as 
percentage of uninfected cells. Western blot analysis was performed on cell culture supernatant for HMGB1(c). 
Nitrocellulose membrane was stained with Ponceau Red as loading control. Cathepsin B is not necessary for T. gondii ME49 
induced IFN-γ dependent host cell necrosis.   
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4.8 T. gondii avirulent strain induced IFN-γ-dependent necrosis dominates over the 
virulent strain resistance mechanisms against IFN-γ protection.    
The IFN-γ-induced cells infected with T. gondii virulent strain (RH-YFP) do not undergo 
necrotic death, as showed in Figure 4.9b. It has been also shown that IFN-γ treatment failed to 
efficiently control the proliferation of T. gondii virulent strains in MEFs (Figure 4.10). 
Furthermore, the accumulation of IRG proteins onto the PVM of T. gondii virulent strain is 
largely blocked, and the vacuoles are not disrupted (Khaminets, manuscripts in preparation). 
Therefore, T. gondii virulent strains have a resistance mechanism against IFN-γ mediated 
protection of host cells, while T. gondii avirulent strain was killed in the IFN-γ-treated cell 
cytosol after vacuolar disruption, and followed by host cell necrosis. Taken together, it was 
therefore of interest to know whether in cells doubly infected with virulent and avirulent 
strain of T. gondii, the virulent or avirulent phenotype would be dominant. To answer this 
question, co-infection of avirulent strain ME49 and virulent strain RH-YFP was performed 
and host cell viability was measure 8 hours after infection. Figure 4.15 shows that the 
viability of host cells co-infected with both ME49 and RH-YFP strains was decreased in the 
same manner as ME49 infection alone in the presence of IFN-γ. The resistance effect against 
IFN-γ from RH-YFP strain was overcome. This must illustrate that the IFN-γ-dependent host 
cell necrosis induced by the avirulent ME49 strain overcomes the resistance to IFN-γ 
induction typical of the virulent RH-YFP strain. This is, at least partially, due to the fact that it 
fails to induce necrosis, but has no resistance to necrosis once induced (in our case by co-
infecting of ME49 strain). This in turn suggests that the necrotic event is triggered by 
vacuolar disruption, which fails to occur for the virulent strains. It is therefore plausible that 
this failure of disruption is in turn due to the defective loading of IRG proteins onto the T. 
gondii virulent strain vacuoles. 
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Figure 4.15 IFN-γ-dependent host cell necrosis elicited by T. gondii avirulent strain dominates over the IFN-γ 
resistance mechanisms of T. gondii virulent stain. 
MEFs were seeded into 96 well plates (7.5x103/well) and treated with 200U/ml IFN-γ or left untreated for 24 hours. T. gondii 
avirulent strain ME49 and/or virulent strain RH-YFP were infected for 8 hours. Cell viability were measured and expressed 
as percentage of uninfected cells. ME49 infection caused IFN-γ dependent host cell death while RH-YFP did not, even in the 
present of IFN-γ. However, when ME49 and RH-YFP were coinfected in the presence of IFN-γ, host cell viability was 
decreased to the same level caused by ME49 infection alone.  
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5. Discussion 
IRGs family members are indispensable resistance factors against intracellular pathogens in 
mice. Cellular membrane system is the frontier where intracellular pathogens are confronted 
with host resistance factors. Studies on the subcellular localization provide important 
information for the functions of the IRG proteins. In the present study, subcellular localization 
of endogenous Irgm1 and Irgm1 tagged by EGFP were investigated in depth. Furthermore, 
the cell-autonomous resistance mechanisms were extensively analyzed in the T. gondii 
infection model by live cell imaging and the possible role of Irgm1 in T. gondii resistance was 
examined.   
5.1 Irgm1 localizes mainly to the Golgi apparatus and lysosomes, and mislocalizes as a 
result of EGFP-tagging at the N or C terminus. 
Different members of IRG proteins showed different affinities to cellular membranes. Irgm1 
has been found exclusively in membrane-bound form in cells and behaves like a 
transmembrane protein in biochemical assays even though no transmembrane domain has 
been identified within the protein sequences. In L929 fibroblasts, TIB-75 hepatocytes and 
Raw 264.7 macrophages, Irgm1 localizes to cis- and medial-Golgi apparatus with additional 
distributed granular signal (Martens 2004b). In the present study, by using TGN38 as a trans-
Golgi and trans-Golgi network (TGN) marker, Irgm1 is further identified to be localized in 
these compartments as well. In addition, the distributed granular signals of Irgm1 overlap 
with those of LAMP1, which marks late endosomes and lysosomes. This observation is 
confirmed since Irgm1 has also been found to accumulate on the compartments enriched in 
the acidotropic dye LysoTracker. In addition, immunofluorescent staining shows that CI-
M6PR and Irgm1 localize to adjacent compartments or partially colocalize. The steady state 
distribution of CI-M6PR is predominantly within late endosomes, less in the TGN and ~10% 
at plasma membrane, but not in lysosomes. It is therefore likely that in addition to Golgi state, 
Irgm1 is mostly distributed in the lysosomes, rather than in the late endosomes. Compared to 
the universal Golgi localization of Irgm1, the signal intensities of Irgm1 in the LAMP1- 
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Table 5.1 Summary of the localization of Irgm1, EGFP-tagged Irgm1 and EGFP-Irgm1 αK 
 
IFN-γ induced 
Irgm1 
Transfected 
Irgm1 
Irgm1 S90N EGFP-Irgm1 Irgm1-EGFP 
EGFP-Irgm1 
S90N 
Irgm1-EGFP 
S90N 
EGFP-Irgm1 
αK 
Golgi + + + – – + + + 
LE/LY + + – – + – – + 
EE/RE – ND ND + + – – – 
PG + + – – + – – – 
Abbreviations: LE/LY: late endosome/lysosome; EE/RE: early/recycling endosome; PG: latex bead containing phagosome; 
ND: not determined. See detailed descriptions in the text. 
 
positive compartments vary in different individual cells, from obviously visible to hardly 
detectable. Since the MEFs are isolated from mouse embryos and composed of heterogeneous 
groups of cells, the variable degrees of lysosomal association of Irgm1 could correlate with 
the different states of individual cells controlled by cell cycles or other undefined factors. 
Finally, scarcely detectable amount of IFN-γ induced endogenous Irgm1 is found associated 
with early and recycling endosomes by comparing fluorochrome-labelled transferrin with 
Irgm1 localization. To conclude, the IFN-γ induced endogenous Irgm1 localizes to the whole 
Golgi apparatus and late endocytic/lysosomal compartments.  
Both N and C terminally EGFP-tagged Irgm1 mislocalize in MEFs (Results-I) and Raw264.7 
macrophages (Könen-Waisman, unpublished). Both of them do not localize to the Golgi 
apparatus anymore. Irgm1-EGFP shows significant association with LAMP1-positive 
compartments in all transfected cells, in contrast to the variable lysosomal association of IFN-
γ-induced endogenous Irgm1. It also mislocalizes to the early/recycling endosomes defined by 
the uptaken transferrin, since endogenous Irgm1 shows scarcely, if at all, early/recycling 
endosomal distribution. EGFP-Irgm1 associates with LAMP1-positive compartments very 
weakly, if at all. It is distributed mainly in the early/recycling endosomes as well as some 
other undefined, non-Golgi, non-LAMP1-positive, vesicular structures. However, both N and 
C terminally EGFP-tagged nucleotide-binding deficient Irgm1 (S90N) restore the correct 
Golgi localization with almost diminished mislocalization. This indicates that the 
localization/mislocalization of Irgm1 are controlled by the nucleotide binding, and 
accordingly may reflect the inactive/active state of the protein. One member of the IRG 
proteins, Irga6, shows GTP-dependent oligomerization and self-activation (Uthaiah 2003). In 
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addition, Irgm1 has been shown to interact with itself in yeast 2-hybrid system, and this self-
interaction is abolished by destroying the nucleotide-binding motif (S90N) (Hunn 2007). 
Considering that the transfected EGFP proteins form dimer in cells, one possibility for the 
mislocalization of Irgm1 by an EGFP-tag could be that the interaction of two Irgm1 
molecules is promoted by the EGFP dimer, thus stimulate the GTP-dependent activation of 
Irgm1.  
Golgi localization may indeed reflect the inactive form of Irgm1 since nucleotide-binding 
deficient Irgm1 (S90N), no matter tagged with EGFP or not, localizes to Golgi. However, 
more cytoplasmic vesicular signals have been noticed in addition to Golgi localization when 
Irgm1 (S90N) and EGFP-tagged Irgm1 (S90N) were expressed. Those signals showed partial 
and weak overlapping with LAMP1/Transferrin positive compartments in some transfected 
cells (data not shown). This may reflect the weak capability of Irgm1 to associate passively 
with early/recycling/late endocytic/lysosomal compartments, but active accumulation on 
those organelles may be under strict control by nucleotide binding.  
Accordingly, the early/recycling/late endosomal and lysosomal localization of EGFP-tagged 
Irgm1 could reflect the activated form of Irgm1. Activated Irgm1 may target to the lysosomes 
by interaction through N-terminus, since the lysosomal association for EGFP-Irgm1 is largely 
abolished. As discussed later, a helical fragment near C-terminus of Irgm1 (αK) is responsible 
for its lysosomal targeting. However, based on the crystal structure of Irga6, a prototypic 
structure for all IRG proteins (Ghosh 2004), the N-terminus of the protein is close to the αK 
helix. In contrast, the C-terminus of the protein is far from αK helix and locates in another 
side of the molecule. Therefore, it is reasonable that the EGFP tagged at N-terminus, but not 
at C-terminus, may interfere with the interaction of αK helix with its lysosomal target when 
Irgm1 is in its activated form. On the other hand, the early/recycling endosomal targeting of 
Irgm1 is probably independent of αK helix, because both N and C terminally EGFP-tag does 
not interfere with the early/recycling endosomal mislocalization of tagged Irgm1. 
Furthermore, EGFP-αK targeting construct does not target to the early/recycling endosomes 
(data not shown). Endogenous Irgm1 has been shown to be rapidly recruited to active plasma 
membrane and phagocytic cups, probably mediated by its activated G-domain (Martens 
2004b). Subsequently, Irgm1 remained association with phagosomes as they mature (through 
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early endocytic pathways) into LAMP1-positive phagolysosomes. Over-expressed Irgm1 and 
its isolated G-domain localize to the plasma membrane in L929 cells, and this is also 
abolished when Irgm1 (S90N) is over-expressed. Therefore, it is not implausible that a 
proportion of EGFP-Irgm1 and Irgm1-EGFP are recycling between plasma membrane and 
early/recycling compartments mediated by the activated G-domain. One hint in favour of this 
hypothesis is that, in the proposed molecular structure, in contrast to the αK helix, the G-
domain of the protein is distant from both N and C terminus, and therefore should not be 
directly influenced by EGFP-tag.  
Nevertheless, the activation mechanism of Irgm1 controlled by the nucleotide binding and 
hydrolysis is obscured by the fact that Irgm1 has an unusual methionine in G1-motif in place 
of the otherwise universally conserved lysine, a property shared by the two other members in 
the IRGM subfamily. The well-conserved lysine in G-1 motif is responsible for binding the 
phosphates of the nucleotide and is important for hydrolysis activity of the GTPase. Several 
studies on other GTPases have shown that mutation of this conserved lysine interferes with 
nucleotide binding and hydrolysis (Bourne 1990; Bourne 1991). Especially in Mx proteins, 
substitution of a methionine for the lysine in G1 motif, same substitution in Irgm1, resulted in 
a loss of GTPase activity (Pitossi 1993). Little has been reported about the biochemical 
properties of Irgm1, except that the protein binds to GDP cross-linked to agarose beads, but 
not GTP and GMP (Martens 2004a). Taylor and colleagues reported that more than 90% of 
the nucleotide bound to immunoprecipitated Irgm3 is GTP (Taylor 1997). In addition, 
partially purified GST-Irgm3 has been shown to hydrolyze GTP to GDP, although GTP-
binding deficient control (S98N) was missing in these experiments (Taylor 1996). It is also 
interesting to note that N-terminally EGFP-tagged Irgm2 and Irgm3 have the same 
localization as endogenous Irgm2 and Irgm3 in cells (Golgi and ER, respectively)(Martens 
2004a). Taken together, Irgm1 may have dramatic different nucleotide binding and/or 
hydrolysis properties from classical GTPases as well as other IRGM proteins and biochemical 
studies on recombinant proteins are essential for further investigations. 
Irga6 and Irgb6 form GTP-dependent aggregates and mislocalize when expressed alone in 
cells. However, this mislocalization can be reversed by treating cells simultaneously with 
IFN-γ. It has been established that the IRGM proteins are the IFN-γ induced factors 
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responsible for proper localization of Irga6 and Irgb6. The current model is that IRGM 
proteins interact with Irga6 and Irgb6, prevent GTP binding by those proteins, and keep them 
in GDP-bound inactive form (Hunn 2007). In contrast, the mislocalization of Irgm1 by EGFP-
tag is not influenced by IFN-γ co-treatment. The explanation again awaits the biochemical 
studies on recombinant Irgm1 proteins, as the mislocalization is indeed nucleotide-binding 
dependent. 
The accumulation of Irgm1 on the phagosomes may largely reflect the critical biological 
function of this protein. Irgm1 deficient mice lose resistance to a broad range of intracellular 
pathogens, such as T. gondii, T. cruzi, M. tuberculosis, S. typhimurium and L. monocytogenes 
(Collazo 2001; MacMicking 2003; Santiago 2005; Henry 2007). Although those pathogens 
have diverse intracellular life styles, they share one common property: they can establish and 
reside in non-fusogenic pathogen-containing vacuoles after invasion into (or being taken up 
by) the host cells. However, the signal for Irgm1 to accumulate on phagosomes is probably 
pathogen-irrelevant, as phagocytosed latex beads is enough to recruit Irgm1. The 
accumulation of Irgm1 on phagosomes is strictly nucleotide-binding dependent. IFN-γ 
induced endogenous Irgm1, transfected Irgm1 and Irgm1-EGFP fusion protein strongly 
associate with latex beads-containing phagosomes, but this accumulation is completely 
abolished when the nucleotide binding G1-motif is destroyed. Considering that IFN-γ-induced 
endogenous Irgm1 has variable degrees of lysosomal associations, this could imply that Irgm1 
may actively recycle and patrol in the endocytic compartments, because the lysosomal 
fraction of Irgm1 could be the spontaneously activated form of the protein. Macmicking et al 
have shown that Irgm1 could function by accelerating the acidification of M. tuberculosis-
containing phagosomes, and Irgm1-deficient macrophages could not efficiently kill 
intracellular M. tuberculosis upon IFN-γ treatment (MacMicking 2003). Nevertheless, the 
resistance mechanisms of Irgm1 for other pathogens remain to be examined. For example, L. 
monocytogenes escapes from the phagosome within 30 minutes after uptaking to replicate 
within the cytosol while T. gondii actively invade all nucleated cells independent of the 
phagocytosis pathway (Tilney 1989; Portnoy 2002; Sibley 2004). The single phagosomal 
acidification mechanism may not explain the central role of Irgm1 for resistance against all 
those pathogens. Recently Macmicking et al have produced evidence that Irgm1 could also 
 80
 
                            Discussion  
accumulate on the L. monocytogenes- containing phagosomes (Shenoy 2008). Indeed, the 
escape from phagosomes by L. monocytogenes is efficiently blocked in the IFN-γ-treated 
macrophages (Portnoy 1989). It is therefore possible that Irgm1 could execute different 
mechanisms against different pathogens. 
Deretic and colleagues reported that Irgm1-EGFP (pF25) colocalized with MDC and LC3 
positive compartments, suggesting that Irgm1 associates with autophagosomes and therefore 
has a pro-autophagy function in macrophages (Gutierrez 2004; Singh 2006). However, 
whether this association of Irgm1 with autophagosomes is actively autophagy-promoting or is 
only a secondary association remains to be further examined, since Irgm1-EGFP is showed in 
the present study to associate constitutively with lysosomes. More importantly, Irgm1-EGFP 
behaves differently from endogenous IFN-γ induced proteins and IRGs proteins also 
cooperate with each other (Hunn 2007). Thus the transfection of Irgm1-EGFP alone is a 
highly artificial situation and the conclusion of Gutierrez and Singh et al remains to be 
confirmed.  
Irgm1 is the only member in IRG family which has been found so far to associate with 
endocytic compartments. Irgm2 and Irgm3 are exclusively associated with Golgi apparatus 
and endoplasmic reticulum, respectively. Irga6 and Irgb6 are partially ER-residing proteins 
and partially cytosolic. And Irgd is largely cytosolic in cells (Taylor 1997; Martens 2004b; 
Butcher 2005; Martens 2006). In addition, Irgm2 is not recruited to latex bead-containing 
phagosomes (data not shown). Due to ER-localization of Irgm3 and Irga6, it was technically 
difficult to distinguish between accidental proximity and active association with the 
phagosomes of these proteins. However, it is clear that Irgm3 and Irga6 do not accumulate in 
significant amounts on latex bead-containing phagosomes as Irgm1 does (Martens 2004a). 
Preliminary data also indicate that Irgb6, Irgb10 and Irgd are also not accumulated on latex-
beads phagosomes (data not shown). Interestingly, those who are not associated with latex 
beads phagosomes have been found to extensively accumulate on T. gondii avirulent strains 
PVM, from where Irgm1 is absent. Currently we consider the free diffusion from cytosolic 
pool to the T. gondii PVM as the re-localization mechanism. Irgm1 has been identified so far 
to be the only member of the IRG family that exclusively associates with membrane with no 
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free cytosolic pool. This may provide additional support for the diffusion model of the 
recruiting of other IRG proteins to the T. gondii parasitophorous vacuole.  
5.2 Both Golgi and lysosomal localization of Irgm1 is dependent on a predicted 
amphipathic helix near the C-terminus.  
Golgi localization of Irgm1 has been shown to be mediated by the αK helix near the C-
terminus. This helix is predicted to be amphipathic and is sufficient to target EGFP protein to 
the Golgi apparatus when tagged at the C-terminus. Disruption of amphipathicity by insertion 
one or two glutamate residues into helical region abolishes the Golgi localization of the 
EGFP-αK construct as well as of the Irgm1 full-length protein (Martens 2004a). In the present 
study, Irgm1 has been further identified to localize in lysosomes defined by LAMP1, in 
addition to the Golgi apparatus. EGFP-αK was therefore examined in more detail for its 
localization in MEFs. Nearly half of EGFP-αK expressing cells show Golgi localization 
defined by GM130 and another half show punctate structures throughout the cytoplasm. 
Many of those punctate structures overlap with LAMP-positive compartments, indicating that 
EGFP-αK, like native Irgm1, localizes to lysosomes as well. Interestingly, Golgi and 
lysosomal localization of EGFP-αK has been observed simultaneously only in a small 
proportion of transfected cells (14%). This may correlate with the observation that IFN-γ 
induced endogenous Irgm1 shows different levels of lysosomal association, with strong 
lysosomal signals in some cells while with hardly detectable signals in other cells. The 
mechanism is unclear. It could be that the lysosomal association is regulated by cell cycling, 
for instance. The Golgi/lysosomal localization of EGFP-αK has been observed in L929 
fibroblasts as well as Raw 264.7 macrophages, indicating that the targeting mechanism is not 
cell type specific. Some of the punctate signals from EGFP-αK expressing cells show overlap 
neither with GM130/LAMP1 nor with early/recycling endosomes, suggesting the additional 
membrane associations of EGFP-αK, whose identity remains to be defined.  
The Irgm1 αK helix is not only sufficient for targeting EGFP protein to Golgi/lysosomes, but 
also required for the localization of full-length protein. A mutant with glutamate insertions to 
disrupt the amphipathicity of αK helix in full-length Irgm1 distributes as uncharacteristic 
dotty structures throughout the cytoplasm, which show no overlap with GM130 or LAMP1. 
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This observation has at least two implications: first, Golgi and lysosomal localization of full-
length Irgm1 depends on the amphipathicity of the αK helix; secondly, Irgm1 protein has 
additional membrane binding motif(s) since the glutamate insertion mutant does not distribute 
as a free cytosolic protein. For instance, the isolated G-domain of Irgm1 localizes to the 
plasma membrane, indicating that the G-domain of the protein also has a membrane 
association property (Martens 2004b). However, although Irgm1 αK helix is sufficient to 
target EGFP protein to Golgi and lysosomes, it is not sufficient to target EGFP to the latex 
beads-containing phagosomes. Full-length Irgm1 is accumulated on phagosomes depending 
on the integrity of nucleotide-binding motif. It is therefore plausible that nucleotide-binding 
dependent conformational change of full-length Irgm1 regulates the exposure of αK helix to 
its binding partners on lysosome/phagosome. However, this hypothesis does not exclude the 
possibility that other region in the Irgm1 protein could contribute to the phagosomal 
accumulation of this protein.  
An alanine scan was performed to investigate the possible mechanism of Golgi/lysosomal 
localization of EGFP-αK construct. Single mutations for each individual residue in αK helical 
region and double/quadruple mutations for hydrophobic residues do not change the 
Golgi/lysosomal localization of EGFP-αK. When more than two non-hydrophobic residues 
are substituted to alanines, the mutants distribute in an uncharacteristic reticular structure 
throughout the cytoplasm, which displays neither overlapping with GM130 nor with LAMP1. 
These results suggest that both the overall amphipathicity of the αK helix and the identity of 
the non-hydrophobic residues contribute together to the membrane and Golgi/lysosome 
localization of the αK helix. The contribution of the non-hydrophobic residues needs further 
analysis as it is unclear whether the effect observed from the double/triple non-hydrophobic-
residue to alanine mutations is primarily due to an increase in overall hydrophobicity or to the 
loss of the specific polar side-chains. In addition, there are two basic residues (K349, R351) 
and three large hydrophobic residues (L350, L352, M353) preceding the predicted 
amphipathic helix which were not analyzed in the present study. Altogether there is a high 
frequency of basic residues in this targeting sequence. Therefore, it is possible that those basic 
residues can interact with phosphate groups of the lipid bilayers. Recently Macmicking et al 
have suggested that Irgm1 interact with specific phosphoinositides generated on internal 
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membranes and the glutamate insertion mutants also interfere with this specific binding 
(Shenoy 2008). This may provide new insight into the targeting mechanism of Irgm1, in 
which αK helix definitely plays a important role. 
Not only Irgm1, but all IRGM proteins have a membrane-targeting signal which corresponds 
to the αK helix in the Irga6 crystal structure (Martens 2006). The αK helix from Irgm2 targets 
EGFP to the Golgi apparatus and the αK helix from Irgm3 targets EGFP to a reticular 
endomembrane system, which largely overlaps with the localizations of respective full-length 
proteins. Although αK from Irgm1 is predicted to be amphipathic, neither of the equivalent 
αK from Irgm2 and Irgm3 has a predictable pronounced amphipathic character and that of 
Irgm2 is not even noticeably hydrophobic. Efforts to purify IRGM proteins for biochemical 
analysis have not been successful so far. Therefore it could be possible to take advantages of 
those small targeting peptide to study the subcellular localization of IRGM proteins. Initial 
trials to purify recombinant EGFP-αK of all three IRGM proteins from E.coli failed due to 
extensive proteins degradation in the bacteria (data not shown). Therefore the αK peptides 
from IRGM proteins were synthesized and covalently labelled with biotin so that they could 
be later loaded onto the tetrameric streptavidin protein, which has four biotin binding sites. In 
addition, there are at least three advantages to use peptide-streptavidin tetramer system. First, 
since peptide from Irgm1 and Irgm3 were not soluble in neutral pH buffers, they had to be 
first dissolved in 10mM NaAc pH4.5 buffer with 10mM TCEP as reducing agent. However 
streptavidin is a 60kDa tetrameric protein that is extremely soluble in neutral solution. 
Furthermore the dissociation constant (Kd) of the biotin-streptavidin complex is on the order 
of ~10-15M, ranking among one of the strongest known non-covalent interactions that is 
essentially irreversible (Weber 1989). Therefore when peptides were loaded onto streptavidin 
protein, the solubility of peptides was significantly increased. Secondly, EGFP forms a weak 
dimer when expressed in the cell. The streptavidin is a natural tetrameric protein and each 
molecule has the capacity to bind four biotinylated peptides, resulting in enhanced affinity of 
targeting peptides to their binding partners. Thirdly, streptavidin can be covalently labelled 
with fluorochromes and used directly in the fluoro-cytochemistry staining. Irgm1 αK peptide 
has been tested to successfully mimic the localization of endogenous full-length Irgm1 in both 
Golgi apparatus and lysosomal compartments in MEFs (Figure 3.18) and L929 cells (not 
 84
 
                            Discussion  
shown). Similar results were obtained using streptavidin-αK peptide from Irgm3, which 
displayed reticular staining pattern mimicking full-length Irgm3 in L929 fibroblasts (not 
shown). The streptavidin-αK peptide from Irgm2 stains the overall, unspecific cellular 
structures by the same experimental method, which does not mimic the localization of the 
endogenous protein. This indicates that the Irgm2 αK could have different targeting 
mechanisms.  
Further experiments would become feasible using the artificial targeting-peptide-streptavidin 
complex. For instance, as suggested by a recently publication (Shenoy 2008), Irgm1 could 
bind to specific phosphoinositides generated on cellular membranes. Therefore, in vitro lipid 
vesicle binding experiments could be performed to test specific lipid binding affinities using 
the targeting peptides.  
5.3 Irgm1 is not absolutely necessary for IFN-γ-dependent cell-autonomous resistance 
against T. gondii. 
At least 5 members have been observed to accumulate massively onto the PVM of avirulent T. 
gondii in primary astrocytes, primary embryonic fibroblast and 3T3 fibroblast lines (Martens 
2006 and unpublished). However, we could never detect Irgm1 on the PVM although this 
observation was obscured by the fact that the Irgm1 antiserum A19 cross-reacts to some 
extent with the T. gondii itself. In the present study, the absence of Irgm1 from avirulent T. 
gondii vacuoles has been confirmed in MEFs by using non-cross-reacting goat antiserum P20 
and monoclonal antibody 1B2. In addition, an independent group also reported that they could 
not observe Irgm1 on T. gondii vacuoles in macrophages (Butcher 2005). It is a striking 
observation considering that Irgm1 is indispensable for mice to survive the acute phase of T. 
gondii infection and suggests that Irgm1 may function distantly from the parasitophorous 
vacuole. It is even more striking that the Irgm1-deficient MEFs could restrain intracellular T. 
gondii growth upon IFN-γ induction, essentially as efficiently as the wild type cells.  
As discussed above, other IRG proteins may relocate to T. gondii vacuoles by free diffusion 
from the cytosolic pool. Irgm1 has no cytosolic fraction and exclusively binds to cellular 
membranes (Marten 2004b). This may be the reason for the absence of Irgm1 from parasite 
vacuoles. Additionally we showed that IRGM proteins, including Irgm1, exercise regulatory, 
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non-redundant roles on other IRG proteins. They could interact directly with GKS subfamily 
members and keep them in inactive GDP-bound forms in their resting subcellular residences 
(Hunn 2007). This hypothesis was consolidated by the observation that in Irgm1-deficient 
cells, Irga6 and Irgb6 form aggregates in the cytosol (Figure 3.19, and Taylor, manuscript in 
preparation). This suggests that in the absence of Irgm1, GKS subfamily members could 
undergo spontaneous self-interaction and self-activation, whereas this activation process 
happens, in physiological situation, only when the T. gondii invades the cells and triggers the 
re-localization of IRG proteins onto the parasitophorous membrane. A reasonable conclusion 
may be that the GKS members are responsible for the vesiculation and disruption processes of 
T. gondii vacuoles while the GMS members prevent them from premature activation in the 
resting localization. In Irgm1-deficient MEFs, the amount of Irga6 and Irgb6 accumulated on 
the T. gondii vacuoles was decreased by about 30%, perhaps because spontaneous 
aggregations consumed a certain amount of those proteins. The decreased amount of GKS 
proteins on T. gondii vacuoles may have significance in vivo for the disruption process of T. 
gondii vacuoles. In the in vitro experiments, effectively saturating doses of IFN-γ were used. 
These doses of IFN-γ may induce huge amount of IRG proteins which allows the disruption 
process to proceed despite spontaneous activation and consumption due to Irgm1 deficiency. 
However this may not reflect the real situation in vivo with limited IFN-γ concentrations.    
The elimination mechanism for denuded T. gondii after disruption of the vacuoles remains 
unknown. In primary astrocytes, T. gondii fusion with lysosomes has not been observed at 
any time point after infection (Martens 2005). The same result was obtained in present study 
in primary embryonic fibroblasts. However, Ling et al reported the lysosomal fusion with T. 
gondii in macrophages (Ling 2006). Perhaps this means that the cell-autonomous resistance 
mechanisms for T. gondii are cell-type specific. It is interesting to notice that in that study, 
primed macrophages were used. Therefore, this lysosomal fusion process may need 
participation of adaptive immunity. The authors suggested in their study that Irgm3 is 
necessary for the formation of autophagolysosome around the denuded parasites and for the 
final degradation of the T. gondii. It is interesting to investigate whether Irgm1 may function 
similarly in T. gondii resistance as, indeed, a pro-autophagy function has been suggested for 
Irgm1 in resistance to Mycobacterium infection in macrophages (Gutierrez 2004). Such a role 
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might not necessarily involve the direct accumulation on the T. gondii PVM. Nevertheless, 
there is at the moment no evidence showing that native Irgm1 associates with autophagic 
structures. 
5.4 Loading of Irga6 onto the intracellular T. gondii vacuoles in real time 
We previously reported that at least 5 members of IRG family are accumulated massively 
onto the T. gondii parasitophorous vacuolar membrane by immunocytochemistry staining in 
fluorescence-microscopy and immuno-gold labeling in electro-microscopy (Martens 2005). 
This experimental method provides fundamental information for the function of IRG proteins, 
but could only observe the events in a “fixed” moment. In the present study, a live cell 
imaging system was established and this could allow us to observe the dynamic behaviours of 
IRG proteins (EGFP-tagged Irga6 in this study) as well as intracellular T. gondii in real time. 
As exemplified in figure 4.1, the accumulation of Irga6 onto the T. gondii vacuoles is rather 
variable. First of all, there is a variable lag phase between the entry of the T. gondii and the 
beginning of the detectable accumulation of Irga6. This lag phase ranges from less than 6 
minutes to 26 minutes in the two examples shown in Figure 4.1, and can extend for more than 
12 hours. Indeed, some vacuoles acquire no detectable Irga6 signal as long as the culture 
conditions allowed. This observation may reflect two processes that are confronting each 
other on the parasitophorous vacuolar membrane: namely, the effort of host resistance factors 
to access the PVM and the maturation process of parasite-modified vacuoles tending to 
become less accessible to the host resistance factors and establish a replication-permissive 
niche. Indeed, the vacuole maturation process probably already starts during the invasion of T. 
gondii and PVM formation. In this process most of the host cell proteins are excluded from 
PVM and numerous parasite proteins are inserted into the PVM (Mordue 1999). Therefore the 
lag phase between the invasion of T. gondii and beginning of the loading of IRG proteins 
could reflect a race of IRG proteins (representing host resistance factors) against the 
maturation process of parasite vacuoles. In case of the avirulent T. gondii strain ME49, most 
of the vacuoles are overrun by IRG system within 30 minutes after invasion, while in 
virulence T. gondii strain, like RH, the vacuole maturation process seems to dominate against 
the host resistance factors. Only a few (less than 10%) RH vacuoles are coated with Irgb6 
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(Khaminets, manuscript in preparation). The remaining RH vacuoles are almost free of IRG 
proteins and IFN-γ-dependent cell-autonomous resistance against RH strain is inefficient. 
This argument also suggested, once one T. gondii vacuole can escape the access of IRG 
protein accumulation in the initial phase after invasion, it would become progressively less 
accessible later. This is in turn consistent with the observation that most of ME49 vacuoles 
are coated within 30 minutes after infection. 
Secondly, the progressive accumulation of Irga6, once started, also shows different dynamics. 
In Figure 4.1a the Irga6 signal on the vacuole rapidly reach the maximum capacity of the 
camera in 15 minutes whereas for the second vacuole in Figure 4.1b, it took 50 minutes for 
Irga6 signal to reach the plateau. Currently we assume that the re-localization of IRG proteins 
from their resting residences onto the T. gondii vacuoles is not accomplished by active 
transportation, but rather by free diffusion from cytosolic fraction. The progressive 
accumulation of IRG proteins on the PVM is due to an accelerated GTP-dependent activation 
and homo-/hetero-oligomerization of GKS IRG proteins. According to this hypothesis, we 
could easily conclude that the pace of the accumulation, as well as the final intensity, of Irga6 
on the vacuoles is dependent on the cytosolic concentration of Irga6 protein. This could 
therefore explain the slower accumulation of Irga6 in Figure 4.1b since a previously invaded 
T. gondii has already been coated with and consumed a significant amount of Irga6 proteins. 
The absence of IRG proteins from some vacuoles could also be due to inadequate amount of 
available IRG proteins that results from the protein consumption by the previously invaded 
and IRG-coated vacuoles. In addition, there is a huge variation in IRG intensities on T. gondii 
vacuoles by immunofluorescence staining in fixed samples (Khaminets, manuscript in 
preparation). Accordingly, this huge variation could be partially due to the vacuolar 
maturation process, as mentioned above, and could be also partially due to the asynchrony, as 
well as different multiplicity of infection, which result in the ever-changing cytosolic IRG 
protein concentrations. The latter could be exemplified in the time-lapse images showing the 
evolving Irga6 signal intensities on two vacuoles in a single host cell in Figure 4.1b.  
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5.5 Intracellular T. gondii is killed after the disruption of the parasitophorous vacuole 
Vesiculation and disruption of T. gondii parasitophorous vacuoles during IFN-γ-dependent 
resistance have been observed in primary astrocytes by immunofluorescence staining and 
immuno-gold labeling in electro-microscopy, as well as in primed effector macrophages by 
electro-microscopy (Martens 2005; Ling 2006). In the present study, the disruption of T. 
gondii vacuoles has been observed in real time by using EGFP-labelled Irga6 in live cell 
imaging experiments. The visible disruption itself takes place in a short interval, normally in a 
space of 3 minutes (Figure 4.2). The Irga6-positive vacuoles are suddenly broken at one point. 
Frequently we could observe that during the disruption process, the T. gondii vacuoles, as 
well as the parasite itself observed in phase-contrast illumination (Figure 4.3b), were rounded 
up suggesting that the vacuolar membrane could be under tension before and during the 
disruption. After disruption, the broken vacuoles seem to slip away and the stripped parasites 
seem to recover the original bow-shape (Figure 4.3c).  
The disruption of T. gondii vacuoles is accomplished, at least partially, by IRG proteins. 
Over-expression of Irga6 or Irgb6 could accelerate the vacuolar disruption process while 
expression of dominant-negative Irga6-K89A or Irgb6-K69A results in the impaired control 
of the T. gondii replication in IFN-γ treated primary astrocytes (Martens 2005). Recently, 
members of another family of IFN-γ-inducible GTPases, the p65 guanylate-binding proteins 
(GBPs), have been found to accumulate on T. gondii vacuoles as well (Degrandi 2007). 
Preliminary results showed that mouse GBPs contribute to the resistance to T. gondii. IRG 
and GBP protein families, together with the type I IFN-inducible antiviral GTPases, the Mx 
proteins, share the properties of forming GTP-dependent oligomers and co-operative GTP 
hydrolysis (Martens 2006). These properties relate them to the dynamin family of GTPases, 
which have an established function in membrane fission and deformation (Hinshaw 2000; 
Praefcke 2004). Therefore it is plausible that IRG and GBP proteins could accumulate on and 
vesiculate the parasitophorous vacuolar membrane resulting in the disruption of the vacuoles. 
It remains to be investigated whether IRG and GBP proteins act cooperatively. In addition, 
Irga6 has been shown to interact directly with microtubule motor binding protein, HOOK3 
(Kaiser 2004). Whether this specific interaction could participate in the vacuolar disruption 
process, and how if it does, are also not known. The stripped T. gondii in the cytosol 
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deteriorate after the disruption of vacuoles and become permeable to free cytosolic proteins 
like EGFP or mDsRed, giving a direct indication that the parasite is now dead. Consistently, 
the morphology of the T. gondii in phase-contrast illumination changes from high density to a 
phase transparent form after the disruption of the vacuole.  
The permeabilization of T. gondii indicated by EGFP/mDsRed entry provides a new 
experimental method to define a clear time point of T. gondii death. This method has been 
successfully applied to immunocytochemistry analysis in the PFA-fixed samples as well. By 
using EGFP/mDsRed entry as a marker for T. gondii killing, we have shown that dominant-
negative Irgb6 (K69A) expressing cells clearly have impaired T. gondii killing efficiency, 
therefore directly proving that IRG proteins contribute to the killing of T. gondii (Khaminets, 
unpublished).  
5.6 IFN-γ-treated host cell undergoes necrotic-like death, which could serve as an IFN-γ-
mediated cell-autonomous resistance mechanism against T. gondii  
It is well-documented that intracellular T. gondii can extensively modify host cell signalling 
pathways, resulting an anti-apoptotic state of host cell (Carmen 2007). Accordingly, T. gondii 
infected cells are resistant to numerous apoptotic stimuli, such as UV-irradiation and TNFα 
(Carmen 2006). In the present study, we observed that IFN-γ-treated murine fibroblasts 
infected with T. gondii died after the T. gondii parasitophorous vacuole had been disrupted. 
Although the stripped T. gondii in the cytosol is dead as indicated by the permeabilization of 
parasite plasma membrane, subsequent host cell death seems to be inevitable. Therefore, the 
host cell death could be an active process which serves as an IFN-γ-dependent cell-
autonomous resistance mechanism against T. gondii, including the remaining intracellular 
parasites that have not yet been killed by vacuolar stripping.  
The characteristics of the IFN-γ-dependent host cell death caused by avirulent T. gondii strain 
infection are consistent with necrosis rather than apoptosis. Morphologically, the cytoplasm 
and nucleus of the dying host cell suddenly collapses. Cytosolic proteins (for example 
transfected EGFP) are spilled out to the medium and propidium iodide quickly stains the dead 
cell nucleus, indicating a rapid loss of cell membrane integrity. After the cell membrane 
permeabilization, Annexin-V starts to accumulate on residual cellular membrane material 
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indicating access to internal phosphatidylserine. This is contrary to apoptotic cell death, where 
phosphatidylserine is externalized before the loss of the plasma membrane integrity and 
nuclei of apoptotic cells remain inaccessible to propidium iodide (Goldstein 2000). By 
immunofluorescence staining, cytochrome-c was not found to be released from the 
mitochondria during the vacuolar disruption and host cell death process in IFN-γ treated and 
ME49 infected MEFs, although the possibility that cytochrome-c is released right before cell 
death is not excluded. In apoptosis, cytochrome-c is released from mitochondria about 2 hours 
before the externalization of phosphatidylserine and several more hours before the loss of 
plasma-membrane integrity (Goldstein 2000). Western blot analysis shows that the caspase-3 
and one of its substrates PARP are not cleaved during T. gondii induced IFN-γ-dependent 
host cell death suggesting that the executor caspases are not participating in this process. 
Instead, high mobility group box 1 (HMGB1) is released from cells treated with IFN-γ and 
infected with T. gondii, but not from apoptotic cells. HMGB1, normally functioning within 
healthy cells as an intranuclear architectural protein, has been described as an important 
proinflammatory mediator that is released from cells undergoing necrosis. Once released, 
HMGB1 acts as a potent danger indicator, inducing several inflammatory cytokines to elicit a 
severe inflammatory response (Scaffidi 2002; Chen 2004). Taken together, these results 
suggest that IFN-γ-induced factors cause host cell necrosis upon infection with avirulent T. 
gondii, which serves as a cell-autonomous resistance mechanism against T. gondii. In addition, 
the necrotic host cell death could further promote local immune responses in vivo contributing 
to the control of the T. gondii infection. 
The mechanism(s) of killing the intracellular T. gondii as well as the host cells are unknown. 
The data strongly suggest that there is a functional linkage between disruption of the T. gondii 
vacuole and host cell death. In live cell imaging experiments, disruption of the vacuole, death 
of T. gondii, and then death of the host cell occur always in a definite sequence, though not 
with a definite timing (Table 4.1). Previously we showed that over-expression of Irga6 could 
accelerate the vacuolar disruption (Martens 2005). Therefore the variable timing between the 
infection and the vacuolar disruption in the live cell experiments could be due to the 
heterogeneous expression level of transfected Irga6-EGFP. However, the time intervals 
between the disruption of the vacuoles and the permeabilization of the stripped parasites were 
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rather constant, ranging about 15 to 45 minutes. One simple possibility is that once the T. 
gondii vacuoles have been disrupted, or even earlier when the disruption process starts 
happening, the contents of toxoplasma are release from parasitophorous membrane, 
intermediate space between toxoplasma and PVM, as well as plasma membrane of 
toxoplasma itself, into the host cell cytosol. Those contents could act as foreign danger 
molecules (proteins and/or lipids) which elicit toxic effects from the host cell. These toxic 
effects could in turn kill the denuded T. gondii as well as the host cell. One evidence for the 
release of T. gondii contents accompanied by the vacuolar disruption process has been 
reported (Martens 2005). In IFN-γ induced primary astrocytes, the disruption of intracellular 
T. gondii vacuoles leads to cytoplasmic distribution of toxoplasma protein GRA7, which 
normally localizes on PVM and mediates the nutrient up-take from host cells to the 
toxoplasma (Coppens 2006). Therefore other Toxoplasma proteins/lipids could be released to 
the host cell cytosol in a similar manner.  
The virulent T. gondii strain, RH-YFP, does not elicit significant host cell death in the 
presence of IFN-γ. We have shown that the accumulation of IRG proteins onto the virulent T. 
gondii vacuoles in IFN-γ-induced cells is largely blocked and the vacuoles are not disrupted 
(Khaminets, unpublished). This is consistent with the hypothesis that the disruption of the 
toxoplasma vacuoles causes the host cell necrosis, although it is not excluded that other 
virulence factors could contribute to the resistance of virulent toxoplasma preventing the IFN-
γ mediated host cell death.  
L929 fibroblasts are unable to control T. gondii avirulent ME49 strain infection even induced 
with IFN-γ (Konen-Waisman 2007). Consistent with this, IFN-γ-treated L929 cells fail to 
undergo host cell death when infected with ME49 T. gondii (Figure 4.9c). This in turn proves 
that the host cell necrosis is indeed a cell-autonomous resistance mechanism against T. gondii. 
However why L929 cells can not execute IFN-γ mediated autonomous resistance against T. 
gondii remains a mystery. Preliminary results indicate that in IFN-γ-treated L929 cells, the 
disruption of T. gondii ME49 vacuoles is largely ineffective indicated by the morphology of 
IRG-positive PVM, and the parasites are not permeabilized demonstrated by EGFP-entry 
experiments (Konen-Waisman and Khaminets, unpublished). This would be in favor of the 
hypothesis that the disruption of the parasitophorous vacuoles is the prerequisite for the 
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killing of T. gondii and probably for the host cells as well. Although 6 members of the IRG 
family have been demonstrated to be expressed normally upon IFN-γ induction in L929 cells, 
21 genes (25 coding units) indeed exist in the C57BL/6 mouse genome (Bekpen 2005). 
Further investigation would be then justified to analyze the functions of the whole IRG family 
in L929 cells, and could possibly reveal an elusive component of IRG system as far, which 
would play an important role in cell-autonomous resistance.  
If we assume that the disruption of the T. gondii vacuoles is the trigger for the subsequent 
permeabilization of stripped parasites and probably also the host cells, what would be the 
executors of those events? The participation of executor caspases has been excluded (Figure 
4.13). Based on the morphological characteristics and the timing of the death of the host cells, 
one could daringly suppose that reactive oxygen species could play a role in this process. 
Cells under oxidative stress exhibit necrotic-like death with characteristics like rupture of the 
plasma membrane, spilling out the cell contents, intracellular vesicles swelling (frequently 
could also be observed in the T. gondii infected IFN-γ-induced MEFs) (Fiers 1999; Kroemer 
2005). Extensive oxidative stress (respiratory burst) is a landmark mechanism for the 
activated neutrophils and macrophages to kill the phagocytosed pathogens and finally 
themselves (Segal 2005), a similar process observed in the T. gondii infected IFN-γ-induced 
MEFs. Another candidate for the killing mechanism would be the lysosomal proteases. 
Production of reactive oxygen species could cause lysosomal membrane permeabilization, 
therefore lysosomal proteases could be released and exaggerate the toxic effect (Fiers 1999; 
Guicciardi, 2004). Although Cathepsin B is dispensable for T. gondii elicited host cell 
necrosis (Figure 4.14), other proteases from lysosomes could compensate for the single 
protease defect. Indeed, complete breakdown of the lysosomes with release of high 
concentrations of lysosomal enzymes into the cytosol results in necrosis, whereas partial, 
selective permeabilization triggers cell apoptosis (Bursch 2001, Turk 2002, Guicciardi 2004). 
Furthermore, it has been extensively studied that cytosolic exposure of bacterial components 
could activate the inflammasomes which would subsequently elicit host cell necrotic cell 
death mediated by lysosomal proteases like cathepsins or calpains (Mariathasan 2007; 
Sutterwala 2007). No studies have been reported that T. gondii could activate the 
inflammasome in a similar manner. However, in the condition we observed in the present 
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study, it would not be surprising that some components of stripped T. gondii in the cytosol 
could activate the inflammasome through cytosolic NOD-like receptors. Although 
TLR/MyD88 has been identified as a major class of sensors for T. gondii infection, a role of 
non-TLR, non-MyD88-based recognition and response has been indicated by studies in 
MyD88-deficient mice (Scanga 2002; Kim 2006b). Finally, it is interesting to notice that IFN-
γ could potently induce the expression of lysosomal protease like Cathepsin D, as well as 
enzymes for the production of reactive oxygen species (phox91 and phox67), which have 
potential microbicidal activities (Schroder 2004). Conclusively, the IFN-γ dependent host cell 
necrosis caused by T. gondii avirulent strain infection could be a complex toxic response, 
probably triggered by IRG proteins and participated by several executor molecules. Whether 
the role of the IRG proteins is simply to disrupt the vacuolar membrane, or whether they play 
a further role in transducing the fatal signal will be an interesting issue. Further experiments 
have to be designed and those speculative hypotheses will be tested.  
5.7 Autophagy in cell-autonomous resistance against T. gondii infection 
Autophagy describes the cellular degradative pathway that involves the delivery of 
cytoplasmic cargos to the lysosome (Levine 2008). It is an ancient, highly conserved and 
tightly-regulated process that is essential for cell growth, development, differentiation and 
homeostasis. Compared to the alternative degradation pathway via proteasomes that target the 
soluble short-lived proteins, autophagosomes degrade cell organelles and aggregates of long-
lived proteins in the lysosomes. At least three forms of autophagy have been described: the 
chaperone-mediated autophagy, microautophagy and macroautophagy that differ in their 
physiological functions and the mode of cargo delivery to the lysosomes. Macroautophagy 
involves the de novo formation of isolated double-membrane around the targeted cytoplasmic 
materials and has been suggested recently to play a role in cell-autonomous resistance against 
intracellular pathogens such as viruses, bacteria and protozoa. The cup-shaped 
autophagosomal membrane finally closes and fuses with lysosomes leading to degradation of 
their contents, therefore could target intracellular pathogens as well for elimination in certain 
circumstances (Deretic 2006; Schmid 2007). In addition, it has been known for a long time 
that enhanced autophagy could be observed in dying cells under certain conditions, a 
 94
 
                            Discussion  
phenomenon termed “autophagic cell death”. This type of cell death has been described 
historically by morphological criteria, but whether the role of the autophagy in dying cells is 
cyto-toxic or cyto-protective (but obviously failed) is unclear and still under extensive 
investigations (Levine 2005; Maiuri 2007).  
Several studies have suggested that autophagy could be a mechanism to eliminate intracellular 
T. gondii infection. Ling and his colleagues suggested that T. gondii vacuolar membranes 
were stripped and denuded parasites were eliminated through autophago-lysosome pathway in 
primed mouse macrophages (Ling 2006). Alternatively, but probably dispensable, CD40 
ligation could trigger a similar autophagy-dependent lysosomal degradation mechanism 
against T. gondii intracellular infection in mouse and human macrophages (Andrade 2006; 
Zhao 2007). We previously also reported that EGFP-LC3, a marker for autophagosomal 
membrane, was accumulated in the vicinity of stripped T. gondii in mouse primary astrocytes, 
although lysosome fusion was not observed for either T. gondii vacuoles or denuded parasites 
themselves (Martens 2005). In the present study, we observed that host cell necrosis caused 
by T. gondii avirulent strain infection functions as an IFN-γ-dependent cell-autonomous 
resistance mechanism in mouse fibroblasts. Considering the potential relevance of the 
autophagy in the resistance against T. gondii as well as in the cell death, we were prompted to 
investigate the possible role of autophagy in the host cell necrosis process. Transfected EGFP-
LC3 could associate with T. gondii ME49 vacuoles with or without IFN-γ treatment 
indicating that IFN-γ induced factors, including IRG proteins, are not necessary for the 
initiation of autophagy on the T. gondii vacuoles. Autophagy occurs at low basal level in 
virtually all cells to perform homeostatic functions. Consistently, low level of EGFP-LC3 
aggregation could be observed in uninfected cells. However autophagy is rapidly up-regulated 
when cells are under stress, such as nutrient shortage, oxidative stress, or infection (Levine 
2008). Accordingly, upon T. gondii infection, T. gondii vacuoles could be a default target for 
autophagy as an alien stimulus for the infected cells. However, T. gondii has developed a 
sophisticated strategy to avoid lysosomal fusion inside of the infected cells (Sinai 1997). In 
mouse fibroblasts and astrocytes, this non-fusogenic property of T. gondii vacuoles is 
preserved even when the host cells are treated with IFN-γ. Therefore, direct lysosomal 
degradation does not seem to be an IFN-γ mediated elimination mechanism against T. gondii 
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in mouse astrocytes and fibroblasts. In live cell imaging experiment, no significant amount of 
enhanced EGFP-LC3 aggregation could be observed in the host cell necrosis process. By 
immunofluorescence analysis, enhanced autophagy could be occasionally observed in some 
IFN-γ-treat infected cells at latter time points after infection (Figure 4.5). But considering that 
necrosis processes are uniformly taking place, it is therefore in favour of the hypothesis that 
the host cells are undergo necrosis “with autophagy” rather than “by autophagy”. 
Conclusively, autophagy does not seem to be a major component in either initiation or 
execution phase in IFN-γ-dependent resistance in mouse fibroblasts. It rather seems to 
function as a conserved cyto-protective mechanism which tries to rescue the infected cell, but 
could not succeed.  
It is therefore interesting to notice the discrepancy that the autophago-lysosomal pathway to 
eliminate the T. gondii vacuoles has been documented in the primed macrophages, which is 
clearly dependent on the IRG (Irgm3) proteins (Ling 2006). However, it seems that the IFN-γ 
alone, therefore the IRG system alone, is not sufficient for this process since the unprimed 
macrophages pre-treated with IFN-γ failed to eliminate the T. gondii in a similar lysosomal 
pathway (Ling 2006). Thus it suggests that the in vivo priming could provide additional 
undefined accessory signals for the macrophages to efficiently eliminate the T. gondii through 
the autophago-lysosomal pathway, and this undefined signal from in vivo priming process 
could well be to stimulate the effective autophagosome formation. As we discussed above, the 
disruption of the T. gondii vacuole and the subsequent release of the T. gondii contents 
probably trigger the toxic effect for the stripped toxoplasma as well as the host cell. Therefore 
the effective autophagosome formation and enclosure around the T. gondii vacuoles could 
prevent the toxic effect-inducing agents to be spilled out, which obviously does not happen in 
the primary IFN-γ-induced fibroblasts and astrocytes. In addition, the bone marrow 
macrophages also undergo necrosis when treated with IFN-γ and infected with T. gondii 
ME49 strain (Khaminets, unpublished), indicating that this mechanism is not cell-type 
specific, but is rather conserved in both hemopoietic and non-hemopoietic cells. Taken 
together, we could propose that, during the acute phase of T. gondii infection, the host cell 
necrosis could be an important innate immune response to kill most of the T. gondii and to 
further promote the local immune responses by releasing proinflammatory factors. The 
 96
 
                            Discussion  
autophago-lysosomal pathway could function in the repeated or latter stage of the T. gondii 
infection, which could eliminate the T. gondii without excessive tissue injury.  
5.8 Virulent vs avirulent T. gondii strain infection 
It has long been realized that different strains of T. gondii produce radically different 
pathologies in mice (Sibley 1992; Saeij 2005). The virulent type I strain are universally lethal 
in mice, as a single viable parasite could cause the infected mice to die. In contrast, the 
avirulent strains, the type II and III strains are well tolerated in mice, normally causing a 
chronic latent infection. This difference could be due to the cellular events we described. The 
IFN-γ-treated host cells can autonomously control the avirulent strain growth, but cannot 
efficiently control the infection of the virulent strains. 
As IRG proteins are the major IFN-γ-inducible effectors in cell-autonomous resistance against 
T. gondii infection, it is highly suggestive that the IRG proteins are the targets of the T. gondii 
virulence factors. We have already shown that the accumulation of IRG proteins and 
subsequent vacuolar disruptions are largely blocked by virulent T. gondii strains such as RH 
and BK, probably by targeting the IRG protein Irgb6, which pioneers the access to the PVM 
(Khaminets, manuscript in preparation). Interestingly, this blockade of IRG proteins is 
specific to the individual parasitophorous vacuole membrane since in cells co-infected with 
the virulent and avirulent T. gondii, the accumulation of IRG proteins onto the avirulent 
vacuoles is not blocked by the co-existence of virulent vacuoles in the same host cell. In the 
present study, we further demonstrate that host cell necrosis is an IFN-γ-dependent cell-
autonomous resistance mechanism against avirulent T. gondii strain, but the IFN-γ-induced 
host cells could not efficiently control the virulent T. gondii strain RH-YFP because of its 
ability to avoid eliciting the necrotic reaction. This could in turn due to the blockade of IRG 
accumulation onto the virulent toxoplasma vacuoles, thus avoiding the disruption of the 
vacuoles that is probably the trigger for killing of the stripped parasites and the host cells. 
Finally, we showed that the avirulent strain elicited host cell death is dominant over the 
resistance effect against IFN-γ from virulent strain by co-infection with both virulent and 
avirulent T. gondii strains. This result further demonstrates that the blockade of IRG system 
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by the virulent toxoplasma is mainly focused on the PVM, but it could not block the host cell 
death once the death process is initiated.  
Recently, two polymorphic kinases ROP16 and ROP18 have been identified as the virulence 
factors between different T. gondii strains. ROP16 is secreted from T. gondii and translocates 
to the host cell nucleus, probably functioning by affecting the host STAT signalling pathways 
(Saeij 2006; Saeij 2007). In contrast, ROP18 is also secreted by T. gondii from rhoptries, but 
associated exclusively with the parasitophorous vacuolar membrane (El Hajj 2007). Therefore, 
ROP18 is a strong candidate to counteract the IRG system (and probably also GBPs 
(Degrandi 2007)) on PVM. ROP18 has been experimentally shown to be able to specifically 
phosphorylate one protein in T. gondii extract, but no protein in a Hela cell extract. It is 
plausible that ROP18 could phosphorylate one or more of IRG and/or GBP proteins that is 
recruited to the PVM. By doing so, ROP18 could inactivate IRG/GBP proteins and perhaps 
interfere with their oligomerization, thereby preventing the vacuolar disruption. It is known 
that that the ROP18 allele in avirulent strain yields a tiny fraction (~0.1%) of mRNA 
compared to the amount that is produced by the alleles in virulent strain (Saeij 2006; Taylor 
2006). This could correlate with the strikingly different efficiency in blocking the 
accumulation of the IRG proteins onto the corresponding virulent and avirulent strain 
vacuoles. In addition, the over-expression of ROP18 could enhance the intracellular parasite 
growth. But this effect is again vacuole-specific, meaning only vacuoles over-expressing 
ROP18 could have an enhanced growth in the same cell doubly infected with T. gondii 
expressing normal amount of ROP18 (El Hajj 2007). This further suggests that ROP18 could 
be a virulence factor directly challenging the host resistance factors like IRGs and GBPs on 
the T. gondii PVM. 
5.9 Manipulation of the host cell death: a common theme in the host-pathogen 
interaction 
Programmed cell death (PCD) is essential for development, morphogenesis and tissue 
remodelling, as well as for the immune responses in multicellular organisms. The infection-
induced suicide of host cells following invasion by intracellular pathogens has long been 
realized to be an ancient defense mechanism observed in multicellular organisms of both the 
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animal and plant kingdoms (Gao 2000; Iriti 2007). It is therefore not surprising that persistent 
pathogens, including viruses, bacteria and protozoa, have evolved many different mechanisms 
to modify the host cell death pathways. Generally obligate intracellular pathogens suppress 
host cell apoptotic death. It is more complex for non-obligate pathogens as they could both 
promote and inhibit host cell death depending on the different stages of the infection as well 
as the different host cell types. In addition, the intracellular pathogens could stimulate the 
apoptosis of the uninfected bystander cells, probably to avoid the attack from the immune 
cells (Gao 2000; James 2004; Finlay 2006; Carmen 2007).  
We demonstrate in the present study that the IFN-γ-inducible factors, essentially the IRG 
proteins, could overcome the anti-apoptotic state of the T. gondii-infected cells by eliciting 
host cell necrosis. This result could provide new insight into the investigation of the host-
pathogen interactions. Although large amount of publications have revealed how intracellular 
pathogens could modified the host cell death signalling pathways, little is known about how 
IFN-γ could influence this pathogen-caused cell death modification. This has important 
implications because the resistance against the intracellular bacterial and protozoal pathogens 
is largely dependent on IFN-γ. IRG family members have been shown to be involved in 
resistance against intracellular bacterial pathogens: Mycobacterium, Salmonella, Listeria, 
Chlamydia, as well as protozoan: Toxoplasma, Trypanosoma and Leishmania. All of them 
have been shown to be able to manipulate the host cell death signaling pathways (Gao 2000, 
Carmen 2007). Therefore, studies on the influence of IFN-γ, and especially of the IRG 
proteins, on host cell death pathways manipulated by such pathogens could probably reveal 
new resistance mechanisms of the host innate immunity system.    
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7. Summary 
Immunity-related GTPases are interferon-inducible, indispensable resistance factors against a 
variety of intracellular bacterial and protozoal pathogens in mice. Irgm1 is the most powerful 
member of the IRG family. Previous studies showed that Irgm1 localizes mainly to the Golgi 
apparatus, and relocalizes to phagocytic cups during phagocytosis. Macrophages deficient in 
Irgm1 have impaired acidification of M. tuberculosis-containing phagosomes. In addition, a 
role of Irgm1 in promoting autophagy has been proposed based on EGFP-tagged Irgm1 over-
expression experiments. During T. gondii infection, at least 6 IRG family members 
translocate from their resting localization onto the T. gondii parasitophorous vacuolar 
membrane and contribute to disruption of the T. gondii vacuoles.  
In the present study, Irgm1 has been shown to be associated with late endocytic/lysosomal 
compartments in addition to Golgi apparatus. N or C terminally EGFP-tagged Irgm1 is not 
localized to the Golgi and mislocalizes to the early/recycling endosomes as well as other 
unknown vesicular structures. Both Golgi and lysosomal localization of Irgm1 are mediated 
by a C-terminal amphipathic helix. Although Irgm1 is indispensable for mice to survive T. 
gondii infection, Irgm1 is not recruited to the T. gondii vacuole and is not absolutely 
necessary for the IFN-γ-dependent cell-autonomous control of T. gondii. 
Using live cell imaging, the present experiments show the sequence of events by which IFN-γ 
treated cells eliminate T. gondii. After the invasion of T. gondii, the vacuoles are coated with 
IRG proteins and subsequently disrupted. The stripped T. gondii are released to the cytosol 
and killed. The host cells finally undergo necrosis, and this presumably serves as a cell-
autonomous resistance mechanism. The necrotic host cells release the proinflammatory 
mediator, HMGB1, to further enhance the host immune responses. Virulent T. gondii strains 
do not elicit IFN-γ-dependent host cell death, but could not inhibit the death process once it is 
initiated by co-infection with an avirulent strain. The presented results show that in T. gondii 
infection, the IRG proteins contribute to the disruption of the T. gondii vacuole and this could 
be a trigger for the subsequent parasite killing as well as host cell death.  
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8. Zusammenfassung 
Die Immunity-related GTPasen sind Interferon induzierbare, essentielle Resistenzfaktoren 
gegen ein breites Spektrum intrazellulärer bakterieller und protozoischer Pathogene in der 
Maus. Das stärkste Mitglied der IRG Familie ist Irgm1. In vorherigen Studien wurde gezeigt, 
dass Irgm1 hauptsächlich am Golgi Apparat lokalisiert ist und während der Phagozytose zu 
den sogenannten „phagocytic cups“ relokalisiert wird. Irgm1 defiziente Makrophagen zeigen 
eine verminderte Ansäuerung von Phagosomen die M. tuberculosis enthalten. Basierend auf 
Experimenten in den an EGFP gekoppeltes Irgm1 überexpremiert wurde, wurde eine 
Funktion von Irgm1 in der Stimulierung von Autophagie vorgeschlagen. Während der 
Infektion mit T. gondii verlagern mindestens sechs IRG Proteine ihre Lokalisation an die 
Membran der T. gondii enthaltenden parasitophoren Vakuole  und tragen zur Zerstörung der T. 
gondii Vakuolen bei. 
In dieser Studie wurde gezeigt, dass Irgm1 neben dem Golgi Apparat auch mit dem späten 
endozytischen/lysosomalen Kompartment assoziiert ist. N- oder C-terminal EGFP-
gekoppeltes Irgm1 lokalisiert nicht am Golgi sondern mislokalisiert an den frühen/recycling 
Endosomen und unbekannten vesikulären Strukturen. Die richtige Lokalisation von Irgm1 am 
Golgi und Lysosomen wird durch eine C-terminale amphipatische Helix vermittelt. Obwohl 
Irgm1 essentiell für Mäuse ist um eine Infektion mit T. gondii zu überleben, wird Irgm1 nicht 
zur T. gondii Vakuole rekrutiert und ist nur bedingt essentiell für die IFN-γ-abhängige 
zellautonome Kontrolle von T. gondii. 
Durch den Einsatz von „live cell imaging“ wurde die zeitliche Abfolge von Ereignissen 
aufgeklärt durch die IFN-γ-stimulierte Zellen T. gondii eliminieren. Nach der Invasion von T. 
gondii wird die Vakuole mit IRG Proteinen bedeckt und anschließend zerstört. Die freien T. 
gondii werden ins Cytosol freigesetzt und getötet. Abschließend sterben die Wirtszellen durch 
Nekrose. Diese Nekrose dient wahrscheinlich als zellautonomer Resistenzmechanismus. Die 
nekrotischen Wirtszellen setzen den proinflammatorischen Mediator HMGB1 frei um die 
Immunantwort des Wirts weiter zu stärken. Virulente T. gondii Stämme führen nicht zum 
IFN-γ-abhängigen Tod der Wirtszelle, aber sie können die Einleitung des Todes der Zelle 
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durch Nekrose, hervorgerufen durch Koinfection mit avirulenten Stämmen, nicht unterbinden. 
Die hier gezeigten Ergebnisse zeigen, dass IRG Proteine während der Infektion mit T. gondii 
zur Zerstörung der T. gondii Vakuole beitragen und dass dies der Auslöser für die 
anschließende Eliminierung des Parasiten und den Tod der Wirtszelle sein könnte.  
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